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1. Introduction 
1. 1 Challenges of the current risk assessment 
Manufactured chemicals have a wide dispersion in the environment and derive from many 
different human activities, like medical, industrial and agricultural application. The 
continuously increasing of chemical production and their release into the environment can 
pose a serious risk to environmental and human health. To ensure a high degree of protection 
of human health and environment current legislation in European and other industrial 
countries demand appropriate data on risk assessment of chemicals, pesticides, biocides and 
pharmaceuticals (Commission of the European Communities, 1994; CVMP/VICH 2000; 
EMEA/CHMP, 2006 and VICH, 2004). These data include information on the toxicity at 
various trophic levels and require testing on vertebrates. Solely in the context of the European 
Union Regulation REACH (Registration, Evaluation, Authorization and Restriction of 
Chemicals), a strong increase of animal tests is anticipated. On the contrary, next to ethical 
concerns, the enforcement of the renewed European cosmetic directive (EC/1223/2009) and 
the animal testing law (Directive, 2010/63/EU) arise the need of animal alternative testing 
methods. According to the cosmetic directive, animal test are not allowed anymore for testing 
cosmetic ingredients and products and to comply with the ethical principle of the 3 Rs 
(Reduction, Refinement and Replacement) of Russell and Burch (1959) alternatives are 
mandatory.  
 
In vitro testing appears as an attractive alternative for toxicity testing, as it does not require 
direct animal use. The development and validation of such methods is the aim of the 
European Union Reference Laboratory for alternative methods (EURL) in Ispra, Italy. 
Currently, they are many different in vitro methods routinely used in toxicology testing, 
especially for mechanistic approaches, screenings and research, but their application for 
regulatory use is strongly limited. An in vitro system, which detects the mutagenic potential 
of chemicals and which is accepted and established provides the Ames test  (OECD 471 test 
guidline). Based on auxotrophic mutants of bacteria strains, it finds application in 
pharmaceutical testing and chemical evaluation under REACH. Another example for an in 
vitro test, which is an applied and validated animal alternative test, is the steroidogenesis 
assay (OECD 456, in July 2011). The steroidogenesis assay with H295R cell line detects 
endocrine disrupting chemicals (EDCs) and therefore, replaces the rodent minced testis assay 
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(OECD 440) (Lilienblum, 2008). However, most of these tests are only suitable for screening 
possible toxicity of chemicals, not for definitive hazard identification. Moreover, no in vitro 
assay is able to reveal adverse apical effects (Brion et al, 2012). They cannot reflect the full 
range of chemically induced toxicity, as cell-based in vitro methods do not provide the 
complexity of animal models. Hence, it is in dispute, if in vitro tests alone are capable of 
providing accepted alternative methods. On the one hand, there is a need to reduce assays 
with higher vertebrates and on the other hand screening assays with in vivo properties are in 
demand.  
 
Promising in vivo approaches with small-scale in vitro like attributes use embryos of zebrafish 
(Danio rerio) or Xenopus (Xenopus spp.). The Xenopus Embryonic Thyroid Signalling Assay 
(OECD TG231) for instance provides mechanistic information, as it measures interactions of 
chemicals with the thyroid receptor. Frog embryos represent like the embryos of the 
zebrafish, an intact organism, in which cell-cell interactions and intercellular signal 
transduction is preserved. The advantage of the zebrafish embryos is their closer 
(phylogenetic) relationship to mammals. They have a high number of conserved genes, which 
posses specialized functions also present in higher vertebrates (Embry et al., 2010). Some 
data indicate that zebrafish embryos are suitable models for predicting the toxicity and 
teratogenicity of chemicals in mammals including humans (Nagel, 2002; Selderslaghs et al., 
2009; Strähle et al., 2012). Concurrently, fish embryos are not considered as protected 
animals according to the European Directive on experimental animal use (EU Directive 
2010/63). Based on the assumption that embryos have only a limited or missing pain 
perception in comparison to adults (Belanger et al., 2010; Strähle et al., 2011), the zebrafish 
embryo is regarded by law as a non-animal until the onset of independent feeding. The 
zebrafish is a popular and well-established model in genetics and developmental biology. In 
addition, it is commonly used as a model for drug discovery (Parng et al., 2002; Zon and 
Peterson, 2005; Chakraborty et al., 2009) and in toxicology to study effects of chemicals 
(Carvan et al., 2000).  
 
Furthermore, toxicological research is more and more interested in the identification of the 
mode and mechanisms of action of chemicals (National Research Council, 2007). Potential 
subtle and long-term effects may be indicated by toxicokinetics and toxicodynamics (Fent, 
2003). The uptake, metabolism and excretion (toxicokinetics) are important parameters to 
assess bioavailability and bioconcentration of an environmental chemical in an organism. 
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Furthermore, any toxic effect of a chemical is preceded by an interaction at the molecular 
level (toxicodynamics). The toxic compounds may interact with membranes and receptors 
therein or bind to proteins, what e.g., influence DNA transcription. These interactions result 
in alterations in gene or protein expression, which may mediate the toxic effects on the 
morphological level. Thus, the impact of chemicals comprises all ecological levels, from the 
molecular to the ecosystem level (e.g., food chain) (Fig. 1). But the limited knowledge about 
biological systems has hindered effort to use mechanistic information as a basis of toxicity 
extrapolation and thus, risk assessment (OECD 184, 2013).  
 
 
Fig. 1: Ecotoxicological impact on different biological levels. 
The challenge of risk assessment is to understand the linkage between the sensitive toxicity response on the 
molecular level (mechanistic information) and the individual fitness (organism level) to the more ecological 
relevant population and at least ecosystem level. The use of mechanistic information for ecological risk 
assessment is a prerequisite of the conceptual framework of Adverse Outcome Pathways (AOP). (Figure is 
modified from Fent, 2003) 
 
There is a need for a more ecotoxicological understanding of a potential linkage between a 
molecular initiating event and an adverse outcome across all levels of biological organization 
(Ankley et al., 2010). And to implement a predictive strategy for risk assessment, a sentinel 
system is required, which is suitable to facilitate predictions of realistic pollutant stress 
responses from the molecular to the whole organism and population level. This can not be 
achieved by a single test system but rather by developing the Adverse Outcome Pathways 
(AOPs). The framework of AOPs is a conceptual construct, what collects and evaluates 
relevant chemical, biological and toxicological information to support the use of mode and/or 
mechanism of action as basis for the understanding of adverse effects (OECD 184, 2013). The 
AOPs portrays existing knowledge concerning the pathways of causal linkages between a 
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molecular initiating event (chemicals interaction with e.g., DNA binding, protein oxidation) 
and a final adverse effect at a biological level of organization that is relevant to a regulatory 
decision (Ankley et al., 2010). An adverse outcome can be found on the organism level as a 
change in morphology, physiology, growth, development, and reproduction or on the 
population level. In all cases it results in an impairment of functional capacity and a loss of 
compensation for additional stress or an increase in susceptibility to other influences (IPCS, 
2004; Keller et al., 2012). To promote the AOP concept, more approaches are needed, which 
elucidate the molecular toxicity responses for the identification of mode of action of 
chemicals. Desirable are test systems, which combine the complexity of an intact organism 
with metabolic processes to increase the understanding of toxicity pathways.  
 
1. 2 The zebrafish embryo toxicity test  
Fish are in direct contact with the aquatic environment, which is one of the main sink of 
pollutants. As an aquatic organism they are exposed to chemical substances during their 
whole life cycle and over generations. Their important position in the food chain as primary, 
secondary or tertiary consumer is why they became an important model in aquatic 
ecotoxicology. To date, the application of the zebrafish (Danio rerio) embryo toxicity test 
(zFET) in ecotoxicology has focused on acute toxicity assessments. Acute toxicity in fish 
embryos correlates very well with acute toxicity in adult fish (Nagel, 2002), which is why the 
zFET was suggested to replace the acute fish test (TG, 203, OECD, 1992). In Germany, it was 
already applied for routine wastewater effluent testing (Bundesgesetzblatt, 2005; DIN 15088, 
2007) replacing the acute test on adult golden ide (Leuciscus idus melanotus) (DIN 38412-
L31) since the 1st January 2005. With the adoption of the new OECD 236 test guideline (Fish 
Embryo Acute Toxicity Test, 2013) it is now also internationally accepted to determine the 
fish acute toxicity of chemicals on embryonic stages of zebrafish. Recently, the European 
Centre for Validation of Alternative Methods (ECVAM) published a protocol to promote the 
embryo toxicity test as alternative to the acute fish toxicity test. The protocol describes the 
application of the zFET as a refinement/replacement, reduction part of an integrated testing 
strategy and screening method for higher tier tests (ECVAM DB-ALM, 2013). 
In the zFET according to the new OECD 236 the effects coagulation of the embryo, lack of 
somite formation, non-detachment of tail and lack of heartbeat are considered lethal and 
determine mortality, thus acute toxicity (OECD 236, 2013). Beyond acute toxicity 
assessments, there is plenty of evidence for the potential to also evaluate specific and 
subchronic toxicities like teratogenicity or neurotoxicity (Braunbeck, 2005; Parng et al., 2007; 
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Scholz et al., 2008; Muth-Köhne et al., 2012). The numerous available methods for zebrafish 
open up possibilities to increase the specificity and sensitivity and to improve the 
understanding of toxic effects. Accordingly, the definition of more refined, meaningful and 
quantifiable toxicological endpoints is required to broaden the applicability of the zFET 
(Fraysse et al., 2006; Scholz et al., 2008). Valuable in this context is the gene specific 
promoter-driven expression of fluorescent marker proteins of transgenic fish lines, which 
allow tracing of gene expression spatiotemporally in vivo. This, however, requires a refined 
endpoint evaluation using detailed morphological and submorphological analysis methods, 
which are so far neither established nor standardized. Furthermore, the zFET in combination 
with so-called genomic approaches, which try to elucidate the molecular responses of the 
transcriptome, proteome or metabolome, has increasingly been proposed for the identification 
of modes of actions of chemicals (Scholz et al., 2008).  
 
Nevertheless, the applicability of the zFET is not currently suitable for regulatory standard 
testing as well as for industrial use also in pharmaceutical product development. Despite 
numerous intentions to refine the application of the zFET according to DIN/ISO 15088 
(replacement of the DIN/ISO 38415-6: 2003) or OECD 236 (OECD 236, 2013) for specific 
toxicity assessments (Bachmann, 2002; Hollert et al., 2003, Voelker et al., 2007), an 
important prerequisite for industrial use has not been established yet: for screening, also the 
zFET procedures will need adjustments to high or even middle throughput applications. 
Automation of processes can help to increase time and cost efficiency, which are important 
parameters for commercial test systems, which can be achieved by automation. Therefore, the 
bright field microscopic assessment method of the zFET poses a noticeable drawback as it is 
manually performed. However, a computer-based automated phenotypic assessment of 
embryonic effects by bright field microscopy is not invented so far. The current zFET is 
based on the assessment of characteristic morphological effects on the development of 
zebrafish embryos. Therefore, the orientation of the embryo significantly contributes to the 
quality of the assessment. Only an optimal orientation of the embryo enables the 
determination of all relevant morphological structures, which ensure a sufficient toxicological 
evaluation. A possible approach to solve this difficulty could be provided by computer-based 
3 D-projections, where a virtualized rotation of the embryo can compensate the unfavorable 
position. Present 3 D-projections can only be appropriate achieved for fluorescence images. 
High-capacity computers for the procession of fluorescence image are already available on 
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the market in contrast for bright field images. Thus, automated image recognition and analysis 
could only be achieved for fluorescence techniques. 
 
1. 3 Fluorescence microscopy  
Epifluorescence microscopy reveals only the objects of interest against otherwise black 
background. It requires the object of interest to be fluorescent what can be achieved by a wide 
range of different fluorophores. Fluorescence is the emission of light that occurs after the 
absorption of light of shorter wavelength. The difference between excitation and emission 
wavelength is called Stokes shift, and constitutes the specific property that makes 
fluorescence so powerful. By completely filtering out the exciting light without blocking the 
emitted fluorescence, it is possible to see only the objects, which are fluorescent. If the 
background has no autofluorescence, fluorescence microscopy enables visualization of even 
single fluorescent molecules (Lichtman and Conchello, 2005). The utilization of in vivo 
fluorophores has already become a beneficial tool for the detection of specific cell structures 
or tissues or even gene expression within the living organism.  
An additional advantage of using fluorescent tools concerns image analysis. Fluorescence 
microscopy offers many possibilities of automated computer-based image analysis, which are 
superior to bright field imaging methods due to less complex image features. Fluorescence 
signal based images are easier to process than bright field images, which contain a large scale 
of different grey values or even color information. Moreover there is the possibility of 
fluorescent double stainings, where different structures can be assessed at the same time in the 
same organism, what favors time efficiency. Fluorescence microscopy applications have 
already been established over recent decades in medical research, but still stand at the 
beginning in environmental research.  
 
1. 4 Fluorescence imaging in zebrafish embryos 
The GFP, an intrinsically fluorescent gene product, allows tagging of protein components in 
living organisms. This promotes for example in vivo investigations of developmental 
processes like morphogenesis, as well as the detection of disturbed developmental processes. 
Thus, adverse effects can be visualized and assessed in vivo.  
Hence, fluorescence microscopy finds application in toxicology. Several studies already 
deployed transgenic zebrafish models for simple read-outs to analyze chemical exposure 
induced changes in expression of target genes (Mattingly et al., 2001; Blechinger et al., 2002; 
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Hill, 2003; Behra, 2004; Yu, 2005; Hernández and Allende, 2008; Chen et al., 2009). Hill et 
al. (2003), for instance, linked a dioxin-induced reduction of the brain capacity in zebrafish to 
a decreased expression of neurogenin and sonic hedgehog. They used transgenic zebrafish 
lines expressing GFP under the control of the promoters of these genes, which are two key 
regulatory genes in brain development. The in vivo reporter system of Mattingly et al. (2001) 
allowed the prediction of dioxin-induced toxicity. They used GFP-expression regulated by the 
promoter of the aryl hydrocarbon receptor (AhR), to show that 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD)-exposed transgenic zebrafish embryos express ahr in the eye, nose and 
vertebrae (Mattingly et al., 2001). Tong et al. (2009) developed a transgenic zebrafish 
Tg(cyp19a1b-GFP) line that expresses GFP under the control of the cyp19a1b promoter. This 
line shows co-expression of GFP and endogenous aromatase B in radial glial cells, what 
enables screening of estrogenic activities of chemicals or mixtures in living zebrafish 
embryos (Tong et al., 2009; Brion et al., 2012). The fluorescence intensity of the GFP signal 
in the brain was determined as indicator for estrogenic active compounds. Furthermore, 
Tg(cyp19a1b-GFP) were applied in an effect-directed analysis (EDA) to assess the estrogenic 
activity of environmental sediment samples (Fetter et al., 2014).  
 
The specific promotor-regulated expression of fluorophors can increase sensitivity and 
specificity for the detection of chemical impacts. Analog to the transgenic fish lines, 
fluorescent antibody stainings as well as in vivo stainings with vital-fluorophores can be used 
to visualize substance-induced alterations of tissues or even cells of the zebrafish embryo. In 
our laboratories, for example, we could demonstrate that whole mount immunostainings of 
motorneurons in zebrafish embryos enabled the classification of neurotoxic compounds 
(Muth-Köhne et al., 2012). Also, tissue-specific vital stainings have shown to be applicable 
for effect detection in zebrafish embryos. They are already suggested for drug screening 
applications (Parng et al., 2002). 
These examples illustrate the good potential of zebrafish embryos as a test organism for 
environmental and human risk assessment, as well as a model organism in medical and 
pharmaceutical research and development. In contrast to cell-based systems, their 
characteristic attributes facilitate a direct effect detection in a living organism in real-time. 
Zebrafish embryos are small, transparent and develop ex utero and provide all characteristic 
properties of vertebrates. At 48 hours post fertilization (hpf), the somatogenesis, as well as the 
development of the most organs and extremities are already completed in zebrafish (Kimmel 
et al., 1995). Consequently, complex biological processes based on cell-cell interactions and 
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signal cascades can be assessed during the whole embryonic development. Even if metabolic 
processes are considered in cell-based systems, they cannot provide information on systemic 
effects. The possibility to assess the fluorescent signal in living organism provides the basis 
for an automated image-based phenotypic analysis. Moreover, under laboratory conditions 
several thousand zebrafish eggs are easily available per day, which can be used for a high 
number of parallel experimental treatments (Scholz et al., 2008). The time-, cost- and material 
efficiency of the zFET makes it attractive also for high-throughput applications.  
 
1. 5 Objectives and experimental approach 
The overarching objective of this thesis was to apply fluorescence microscopy methods to the 
fish embryo toxicity test (FET) with the aim to increase the sensitivity and explanatory power 
of the test. The FET is an animal alternative test widely applied in ecotoxicology. Thus far, 
the main application of the FET with zebrafish (Danio rerio) as test species (zFET) focused 
on the assessment of the acute toxicity of chemicals, where only lethal morphological effects 
are accounted for. However, an application of the zFET beyond acute toxicity is evident and 
desirable, but necessitates the establishment of more refined and quantifiable toxicological 
endpoints. I therefore intended to assist its development to an alternative and supplementary 
test method for fish toxicity by improving and accelerating the microscopic assessment 
through fluorescence image analysis. A valuable tool in this context is the use of gene 
expression-dependent fluorescent markers and stains that can even be measured in vivo.  
My task was to compare the fluorescence with standard bright field for the microscopic 
evaluation of the zFET. Particular consideration was given to the practical issues and the 
optimization and automation of image analysis, as these aspects play an important role in 
high-throughput applications. Consequently, I elaborated the benefits of using fluorescence 
applications as convenient tools to identify and specify toxicity in vivo and to increase the 
sensitivity of the zFET. Transgenic zebrafish lines were chosen which enable the assessment 
of the vascular and neuronal development. Furthermore I tried to visualize additional 
structures of the embryos by different staining methods. The whole mount immunostaining of 
the muscle morphology and the vital staining of apoptotic cells appeared as the most 
promising stainings to study further potential chemical-induced effects. The developed 
fluorescence endpoints were scrutinized in a proof-of-principal with chemicals, which have an 
occurrence in the environment, to verify their feasibility for toxicity testing. After testing of a 
bright range of chemicals (pharmaceutical and insecticides), triclosan, genistein and cartap 
were selected as model compounds.  
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The identification of molecular initiating events of toxicity pathways is key for early effect 
detection. Thus, gene expression analysis was chosen to validate the morphological effects, 
which were detected via fluorescence microscopy.  
For the first time, two different phenotypic assessment methods, the microscopic bright field 
assessment of the conventional zFET with different fluorescence-based endpoint methods, 
were directly compared, in terms of their potential to increase the sensitivity and value of the 
zebrafish embryo test system.  
 
An overview of the objectives and the experimental approach of this thesis are illustrated in 
figure 2.  
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Fig. 2: Work flow and objectives of this PhD thesis. 
Numbers refers to the chapters in which the assessment methods are described. DA: dorsal aorta, PCV: posterior 
cardinal vein ISV: intersegmental blood vessel. 
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2. Materials and Methods 
All used materials and the corresponding manufactures (incl. product number) as well as the 
equipment used are described in the following chapters. 
2. 1 Fish husbandry  
The test organism zebrafish (Danio rerio, Hamilton-Buchanan) belongs to the family of the 
Cyprinidae (carp family) within the class of the Osteichthyes (bony fish). It is originally 
found in the branches and tributaries of the rivers in India and South Asia. Males can be 
distinguished from females by their smaller appearance and an orange or reddish tint to the 
silvery bands along their body. Due to the large number of egg production, females can also 
be recognized by their often swollen bellies. They have a very short reproduction circle as 
they reach maturity within three month. One female can spawn about 100 eggs per day, which 
are fertilized by sperm release of the male into the water (Kimmel et al., 1995). Under good 
laboratory conditions several thousand eggs can easily be produced daily. The transparent and 
non-adherent chorions of zebrafish eggs enable an easy observation and manipulation. After 
fertilization embryos develop fully within 48 hpf and hatch between 48 hpf and 72 hpf, 
depending on the water temperature (Kimmel et al., 1995). The optimal temperature for 
zebrafish keeping and raising is 26 ± 0.5°C (Braunbeck et al., 2005).  
 
Transgenic Tg(fli1:EGFP)y1 zebrafish (Westerfield, 1995) were obtained as eggs from the 
zebrafish facility GIGA (Groupe Interdisciplinaire de Géneoprotéomique Appliquée), Liège 
(Belgium). Transgenic zebrafish Tg(gfap:GFP) eggs were kindly provided from the Tübingen 
Zebrafish stock collection (Max-Planck-Institute for Developmental Biology, Tübingen, 
Germany).  Wild type zebrafish were originally obtained from the West Aquarium GmbH 
(Bad Lauterberg, Germany) and maintained for several generations and years in the 
laboratories of the Fraunhofer IME. All zebrafish stocks were raised and kept according to 
high standards of general zebrafish keeping and husbandry (Brand et al., 2002; Lawrence, 
2007). Transgenic fish were handled according to German regulations of genetically modified 
organism (GMO, GVO). Fish were maintained in 100 – 200 l glass aquaria at 27 ± 1°C at a 
14:10 h light : dark photoperiod. For obtaining eggs, metal lattice-covered glass spawning 
trays were inserted into the tanks for 1 h at the beginning of the light period.  
 
All experiments were solely performed on embryos before the start of external feeding. All 
tests were terminated at 48 ± 1.5 hpf (hours post fertilization) and can be regarded as non-
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animal tests according to the legislation and regulations of the German federal state of North 
Rhine Westphalia and the EU Directive 2010/63/EU. Meanwhile, the German law 
harmonized the EU Directive 2010/63/EU and allows testing on fish embryos until the onset 
of independent feeding, which occurs around day 5 post fertilization. 
 
2. 2 Control and model chemicals 
For a proof-of-principle study the newly established fluorescence endpoints should be 
validated using suitable model chemicals in comparison to reference (control) chemicals. 
Firstly, for proofing the validity of this test paradigm, three chemicals were selected as 
control substances: the small molecule SU4312, ethanol and the pharmaceutical 
pentoxifylline.  
SU4312 is a known antiangiogenic compound, for which vascular impairment is confirmed 
(Molina et al., 2007; Tran et al., 2007; Vogt et al., 2009). It was selected as a positive control 
for the ISV-phenotype and length assessment. Vascular endothelial growth factors (VEGFs) 
and their receptors (VEGFRs) are the major regulators of angiogenic signaling by promoting 
endothelial cell differentiation, survival and migration (Ferrara and Alitalo, 1999; Zachary 
and Gliki, 2001; Chan et al., 2002). SU4312 specifically inhibits the VEGFR and thus, 
prevents the ISV outgrowth (Kendall et al., 1999; Molina et al., 2007). Therefore, it was 
suggested as a suitable positive control for the ISV-phenotype and length assessment and in 
addition as negative control for the other fluorescence endpoints. I chose pentoxifylline, a 
synthetic dimethylxanthine drug used to treat circulatory disorders (Oshihma et al., 1981; 
Mueller, 1985) as a negative control for the vasotoxicity assessment. It has haematological 
effects and its main mechanism of action is the inhibition of the erythrocyte 
phosphodiesterase, thereby increasing the intracellular concentration of cAMP (Bessler et al., 
1986; Semmler et al., 1993). An antiangiogenic potential of pentoxifylline has so far not been 
described in the literature. Ethanol served as positive control for the evaluation of the neuro-, 
myotoxic and apoptotic potential. Ethanol is known to act as a neurotoxin, which additionally 
causes axial (teratogenic) defects as well as an increase of the apoptosis rate (Muth-Köhne et 
al., 2012). 
 
In addition, triclosan, genistein and cartap were selected as model compounds. Triclosan is a 
commonly used antibacterial agent in personal care products (PCPs), textiles and furniture. 
Triclosan is effective against microbial growth through inhibition of the enoyl reductase in the 
fatty acid synthesis of bacteria and funghi (Russell, 2004; Dann and Hontela, 2010). 
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Moreover, toxicological studies showed triclosan to act as an endocrine disruptor in fish 
(Foran et al., 2000; Ishibashi et al., 2004) and frogs (Veldhoen et al., 2006). Additionally, 
Oliveira et al. (2009) suggested a vasotoxic potential of triclosan and proposed further 
investigations on the mode of action, as no detailed information are available so far (Oliveira 
et al., 2009). Genistein, a naturally occurring phytohormone present in e.g., soy products has 
been subject of numerous studies because of its known estrogenic activity. Sassi-Messai et al. 
(2009) discovered apoptotic effects in zebrafish embryos, which were estrogen-receptor 
independent and instead caused by inhibition of tyrosine-specific tyrosine kinases of the 
epidermal growth factor (EGF) receptor and of transthyretin amyloidosis (Green et al., 2005; 
Sassi-Messai et al., 2009). Additionally, Kalin et al. (2009) showed antiangiogenic activity of 
genistein in frogs, where it induced a severe ISV-phenotype. Cartap is an insecticide that 
targets the nicotinic acetylcholine receptor at the neuromuscular synapse (Nagata et al., 1997). 
It is known to act as a neurotoxin (Kwak et al., 2000; Zhou et al., 2009; Muth-Köhne et al., 
2012) but no vasotoxic potential has been described as yet. Although, Zhou et al. (2009) 
described an aberrant ISV-phenotype in cartap-exposed zebrafish embryos.  
 
2.2.1 Exposure concentrations 
Zebrafish embryos were exposed from 1 – 2 h post fertilization (hpf) on 48 h to different 
concentrations of the following test substances: ethanol (9065.1, ROTIPURAN®, purity ≥ 
99.8 %, p.a., Carl Roth, Karlsruhe, Germany), SU4312 (S8567, Sigma Aldrich, Munich, 
Germany), pentoxifylline (P1784), triclosan (Irgasan: 72779, Sigma Aldrich), genistein 
(G6649, Sigma Aldrich) and cartap (cartap hydrochloride: 45995, Sigma Aldrich). 
According to initial range finding experiments and the calculated effect thresholds derived 
from the corresponding concentration-response relationships, I defined the following nominal 
test concentrations: ethanol (v/v): 0.5%, 0.71%, 1%, 1.41%, 2%; SU4312: 0.38, 0.61, 0.91, 
1.44, 2.23, 3.48 µM; pentoxifylline: 179.66, 303.83, 593.22, 1019.44 µM; triclosan: 1.38, 
1.73, 1.93, 2.18, 2.45, 2.76 µM; genistein: 7.4, 8.81, 10.47, 12.43, 14.80 µM; cartap: 0.42, 
0.55, 0.67, 0.84 µM.  
 
2. 3 Fish Embryo Toxicity Test  
The Fish Embryo Toxicity Tests were conducted following the draft OECD Guideline for the 
testing of chemicals (OECD 2006) with modifications: 96-well plates were used instead of 
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24-well plates and the lethal as well as sub-lethal morphological effects assessed according to 
the descriptions of Nagel (2002) and Braunbeck and Lammer (2006).  
For the test solution preparation, ethanol, pentoxifylline and cartap were dissolved directly in 
ISO water (prepared according to OECD guideline 203, Annex 2), whereas SU4312 was 
dissolved in dimethyl sulfoxide (DMSO, D8418, Sigma Aldrich), and triclosan and genistein 
at first in a solvent carrier. The stock solution of SU4312 in DMSO was prepared at a 
concentration of 5 g/L (w/v) SU4312 in 100% (v/v) DMSO. Test solutions were prepared by 
dilution of the corresponding volume of DMSO stock solution in ISO water and the addition 
of 100% (v/v) DMSO in order to ensure equal amounts of the carrier DMSO in all treatments. 
A DMSO concentration of 0.03% (v/v) was the minimum to achieve complete dissolution of 
SU4312. Stock solutions for ethanol, pentoxifylline, triclosan, genistein, and cartap had 
concentrations of 0.1 g/L, 1.0 g/L, 0.5 g/L, 1.0 g/L, and 0.1 g/L (w/v), respectively. The 
triclosan and genistein stock solutions were dissolved in 100% acetone (ROTIPURAN®, p.a., 
Carl Roth, Karlsruhe, Germany) and further dilutions were prepared in a final volume of 1 ml 
acetone each, with the dilution factors of 1.26 and 1.19, respectively. These stock solutions 
were used to coat the inner surface of 100 ml-Schott bottles. As solvent control, one bottle 
was coated with 1 ml of acetone only. After coating and complete evaporation of acetone, 100 
ml of ISO water was added to the bottle to dissolve the coated chemicals. The solutions were 
stirred for a minimum of 2 h or until the test substance was completely dissolved and evenly 
mixed. If necessary, the solutions were sonicated for 20 min. To ensure oxygen saturation of 
≥ 90% and provide sufficient agitation, all test solutions were strongly aerated overnight prior 
to test start. In parallel, the U-bottom 96-well microtiter test plates (Greiner Bio-One, 
Frickenhausen, Germany) were saturated with the corresponding test chemical by incubating 
the wells with 200 µl of the test solutions over night at 27°C. The solutions were then 
renewed prior to the test start. For the final tests, one healthy and fertilized egg was 
transferred to each well and exposed for 48 h to the corresponding test solution.  
 
The embryos were microscopically assessed for lethal and sublethal developmental 
morphological effects after 24 and 48 h of exposure via bright field. Although the actual 
assessments took place between 1 and 2 h after 24 and 48 hpf, the denotation of the 
assessment time points were simplified to 24 hpf and 48 hpf to reflect the exposure time. This 
nomenclature is used throughout the text, all data charts and legends. The morphological 
effects were assessed and recorded following the description of the OECD draft guideline for 
the zFET of 2006 (OECD Draft TG 2006) and the background paper of Braunbeck and 
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Lammer (2006). Coagulation, no detachment of tail, no somites, no heartbeat and no 
differentiation were recorded as lethal effects in embryos at 48 hpf. The listing of all effects in 
embryos 24 and 48 hpf is provided in the Annex (8. 1). The data from the morphological 
bright field assessment are displayed as 1) effective concentration values (EC50 value), which 
derived from the concentration-response curves based on probit analysis using ToxRat® 
Professional (version 2.10, ToxRat Solutions GmbH, Alsdorf, Germany) and 2) cumulative 
effects of all embryos in percentage. The results of the effective concentration curves for the 
morphological bright field assessment are named as MBFA for a better discrimination from 
comparison with the qualitative fluorescence endpoint within the Tg(fli1:EGFP)y1 analysis 
(see 3.1.1). The presented zFET results were conducted on embryos of the Tg(fli1:EGFP)y1 
line.  
 
2.3.1 Test design and validity 
For the test, wells of U-bottom 96-well plates were filled with 200 µl of test solution. One egg 
was transferred in one well, respectively. 2 – 3 replicates on individual plates for each 
treatment and control were prepared, where one replicate was defined as 12 embryos on a 
single plate. All tests were repeated independently for 3 times, resulting in three biological 
replicates with 2 – 3 technical replicates respectively, which were pooled for calculation.  
 
To ensure the quality of the zFET results, I applied following validity criteria according the 
OECD draft (OECD Draft TG 2006): 1) the oxygen saturation should be at least 90% at the 
test start, 2) the temperature has to be kept at 26 ± 1.0°C throughout the test, 3) pH of the 
controls should range between 6.8 and 8.0 and the pH of the treatments between 6.5 and 8.5 
and 4) the survival rate in the controls should exceed 90%. If one or more criteria could not be 
met, a test was considered invalid and had to be repeated. 
 
2. 4 Transgenic zebrafish lines Tg(fli1:EGFP)y1 and Tg(gfap:GFP) 
The transgenic zebrafish line Tg(fli1:EGFP)y1, generated by Lawson and Weinstein (2002), 
expresses enhanced GFP (EGFP) under the control of the fli1 promoter, which belongs to the 
E-twenty six (ETS) transcription factor family. Fli1 is crucial for vascular development (Liu 
et al., 2008). It is expressed in the very early haematopoetic precursors within the posterior 
lateral mesoderm from the three-somite stage and later in the endothelial precursors, which 
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develop into the blood vessels of the head and axial- and intersegmental blood vessels (Fig. 3 
A+B).  
 
Fig. 3: Fluorescence images of zebrafish embryos 24 and 48 hpf of Tg(fli1:EGFP)y1  and Tg(gfap:GFP). 
(A) Zebrafish embryos 24 hpf of Tg(fli1:EGFP)y1 (left) and Tg(gfap:GFP) (right) in their chorions. (B) 
Dechorionated zebrafish embryo 48 hpf of Tg(fli1:EGFP)y1. GFP expression is located in the vasculature of the 
embryo. (C) Dechorionated zebrafish embryo 48 hpf of Tg(gfap:GFP), which expresses GFP in the central 
nervous system (CNS). Scale bar: 250 µm.  
 
 
The EGFP-signal persists throughout all stages of development and can also be detected in 
the microvasculature of the fins of the adult fish (Lawson, 2002). The expression is strongest 
in the trunk and tail and can be found in the walls of the major vessels, e.g., dorsal aorta 
(DA), axial vein and intersegmental vessels (ISVs) (Thompson et al., 1998; Brown et al., 
2000). The EGFP-signal of Tg(fli1:EGFP)y1 embryos corresponds to the expression pattern of 
the endogenous Fli1 protein (Lawson, 2002). Therefore, Tg(fli1:EGFP)y1 embryos facilitate 
the in vivo observation of both present and forming blood vessels and thus, of blood vessel 
development.  
The development of the intersegmental blood vessels (ISVs) was chosen as a parameter to 
determine chemical-induced vascular impairment. ISVs sprout out from the dorsal aorta (DA) 
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and run between each pair of somites. Somites are the primary segments of the embryonic 
development of vertebrates, which develop from the mesoderm. The ISVs ventrally follow 
the chevron shape of the somite and more dorsally they cross the somite borders to terminally 
form the dorsal longitudinal anastomic vessel (DLAV) (Isogai, 2003) (Fig. 4). They arrange 
in a regular array and show a characteristic S-like pattern (Serbedzija et al., 1999; Childs et 
al., 2002; Isogai, 2003). The ISV development is time dependent and well described in 
Ellertsdóttir et al. (2010). It is suggested that chemical-induced ISV morphology aberrations 
can be used as an indication of vasotoxicity. 
 
 
Fig. 4: Detailed sketch of the intersegmental vessel (ISV) of zebrafish embryos 48 hpf.  
The ISV is composed of 3 types of endothelial cells (black framed): inverted T-shape cell (red) sprouts out from 
the DA, the connecting cell (green) courses between the somites ventral and dorsally it crosses the somite 
borders and the DLAV connecting T-shaped cell (blue). DA, dorsal aorta; DLAV, dorsal longitudinal anastomic 
vessel; PCV, posterior cardinal vein; ISV, intersegmental vessel. (Figure is modified from Childs et al., 2002) 
 
 
The embryos of the transgenic zebrafish line Tg(gfap:GFP) co-express GFP with the gene of 
the glial fibrillary acidic protein (GFAP), which occurs mainly in the central nervous system 
(CNS) (Fig. 3 A+C). It is primarily expressed in the radial glial cells and astrocytes 
(Bernardos and Raymond, 2006). Next to brain lipid-binding protein (BLBP), GFAP is a 
common radial glial cell (RGC) marker in fish and mammals. RGCs differentiate from 
neuroepithelial cells and serve as a guiding scaffold for newborn neurons to migrate to their 
final destination. They also serve as progenitors of neuronal precursors, astrocytes and 
oligodendrocytes (Xing et al., 2014) but only the RGCs and astrocytes are GFAP-positive 
(Fig. 5). The RGCs represent the major cell type in the neural tube and persist throughout the 
entire life of zebrafish. Therefore, I chose the fluorescence intensity of the neural tube as a 
parameter to determine chemically induced neurodevelopmental impairment. Abnormalities 
in RGC development, function and differentiation as well as cellular interaction (between 
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RGCs and RGCs and neurons), can cause developmental brain disorders (reviewed in Xing et 
al., 2014).  
 
 
Fig. 5: Differentiation of GFAP-positive radial glial cells (RGCs) during CNS development.  
Radial glial cells (RGCs) differentiate from neuroepithelial cells, which serve as progenitors for the 
differentiation into neuronal precursor, astrocytes, oligodendrocytes and also into further RGCs. The GFAP-
positive RGCs and astrocytes are indicated with green stars. In these cells the Tg(gfap:GFP) zebrafish embryos 
express GFP. (Figure is modified from Xing et al., 2014) 
 
 
The fluorescence signal of Tg(gfap:GFP) can be detected in the brain but also weakly in the 
retina, and most prominently in the spinal cord of 24 and 48 hour post fertilization (hpf) 
embryos (Bernardos and Raymond, 2006). The GFAP expression in zebrafish brain is 
reported to begin at the 12-somite stage and persists in the CNS glia of adult zebrafish 
(Bernardos and Raymond, 2006). 
The transgenic embryos were treated and exposed to chemicals according to previous 
description (2. 3). The fluorescence microscope settings for imaging were excitation at 475 
nm and emission at 509 nm for both.  
 
2. 5 Whole-mount immunostaining 
To analyze muscle morphology and thus the myotomal development, whole-mount 
immunostainigs were performed with a specific primary antibody and a fluorescent secondary 
antibody. The primary antibody was F59, a mouse monoclonal antibody (IgG1, kappa light 
chain), which specifically binds to myosin heavy chain and adaxial muscle cells in zebrafish. 
Due to the binding of a fluorescent secondary antibody to the Fc kappa fragment of the 
primary antibody, the muscle structures became visible by fluorescence microscopy. The 
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secondary antibody used was DyLightTM 549-conjugated AffiniPure Goat Anti-Mouse IgG, 
specific for Fc kappa fragment (Jackson ImmunoResearch, Europe, code: 115-505-008). F59 
was obtained from the Developmental Hybridoma Bank, University of Iowa, USA. 
The visualization of the muscle fibers enabled the assessment of the angle between hemi-
segments, as well as of the fiber morphology of zebrafish embryos (Fig. 9). The fluorescence 
microscope settings for analyzing were excitation at 512 nm and emission at 615 nm. Thus, 
the staining method could be conducted on both transgenic lines without losing fluorescence 
signal information as well on wild type embryos.  
 
For the whole-mount antibody staining the control and treated embryos were manually 
dechorionated after 48 h of substance exposure and fixed in 4% paraformaldehyde (PFA) in 
phosphate buffered saline (PBS) for 4 h at room temperature (RT). Then they were rinsed 
three times for 10 min with PBS/0.1% (v/v) Triton X-100 (PBST) and stored at 4°C. I 
performed whole-mount immunostainings as described in a book chapter written by 
Westerfield (2000), with the following modifications: Briefly, fixed embryos were 
permeabilized in ice-cold acetone for 7 min at −20°C, rinsed with distilled water for 5 min 
and washed three times for 10 min with PBST. To prevent nonspecific binding, the embryos 
were incubated in blocking solution (PBST/2% (v/v) normal goat serum) for 4 h at room 
temperature with agitation, and then incubated with the primary antibody (5 µg/ml in blocking 
solution) over night at 4°C. The embryos were washed five times for 10 min with PBST and 
subsequently incubated with the appropriate secondary antibody (1:500 dilution) for 4 h at 
room temperature. They were washed another five times for 10 min with PBST and mounted 
on glass slides in methylcellulose for imaging. 
 
2. 6 Vital staining with acridine orange 
As apoptosis is an important cellular process in embryonic development (Abrams et al., 1993) 
it was the intention to evaluate the potential of the chemicals to influence the normal 
apoptosis rate. Cole and Ross (2001) have described the normal patterns of apoptosis in 
various structures of the developing zebrafish embryos. The dynamics of apoptosis in 
zebrafish embryos follow a time course and mainly occur during neurulation and 
somitogenesis (Cole, 2001). Quantification of the level of apoptosis in zebrafish embryos is 
commonly performed by staining with the vital dye acridine orange (AO) (Parng et al., 2002; 
Tucker and Lardelli, 2007).  
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For staining live zebrafish embryos, control and treated embryos 48 hpf of the wild type were 
incubated in 2 µg/ml acridine orange (Sigma-Aldrich) for 30 min after manual 
dechorionation. After three washing steps of 10 min each in ISO water, the embryos were 
anesthetized in phosphate-buffered benzocaine (4-aminobenzoic acid ethyl ester, E1501, 
Sigma-Aldrich; 2 mM Na2HPO4) and mounted in 3% (w/v) methylcellulose for imaging. The 
fluorescent cells could be detected by an excitation at 502 nm and an emission maximum at 
525 nm. 
 
2. 7 Fluorescence imaging  
For the microscopic assessment, embryos were mounted laterally on a glass slide in 3% (w/v) 
methylcellulose and covered with a cover slip for imaging. 5 – 8 embryos per treatment of 
each assessment method were mounted on one slide, respectively, to assume optimal lateral 
position of at least 3 embryos per treatment for a convenient assessment. To maximize the 
statistical value I tried to analyze more embryos than 3, but due to practicability and time 
effort the number varies between 3 – 5 embryos per treatment and assessment method. Thus, 
the minimal number of embryos assessed was three for each treatment within each 
assessment. For live assessment, embryos were anesthetized in phosphate-buffered 
benzocaine (0.5 mM 4-aminobenzoic acid ethyl ester, E1501, Sigma–Aldrich; 2mM 
Na2HPO4). All embryos were analyzed on a motorized, inverse bright field microscope with 
integrated fluorescence application (Leica System AF6000) and photographed under a 5x and 
10x objective; depending on the examined structure (whole embryos for GFAP expression in 
RGCs and apoptosis measurements, and detailed regions for the assessment of the vascular 
and myotomal structures, respectively). For imaging two different fluorescence filter cubes 
had to be used: for the GFP and AO imaging a filter cube with excitation filter: 480/40 nm, 
dichromatic mirror: 505 nm and suppression filter: 527/30 nm and for the DyLight imaging a 
filter cube with excitation filter: 540/40 nm, dichromatic mirror: 565 nm and suppression 
filter: 610/75 nm.  
Embryos of one assessment method were photographed using always the same microscopic 
settings (exposure, gain and intensity), respectively. Microscopic z-stack images were 
acquired and processed using the Leica LAS-AF software (Leica Application Suite, Advanced 
Fluorescence, version 2.2.0, Wetzlar, Germany), and analyzed using the free software ImageJ 
(National Institutes of Health). All focus areas of the individual images of each z-stack were 
integrated into a full-focused image (extended depth of field) using the ImageJ plugin “Stack 
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focuser”. The full-focused images were subsequently analyzed according to the region of 
interest (ROI, see chapter 3. 1) and the fluorescence endpoint assessed.  
All images were acquired and processed as black and white images (8 bit). For illustration, 
full-focused images were manually colored and edited, like cut to size, color processed, 
contrast control, etc. with Photoshop Adobe® CS4 (version 11.0.2). All shown images 
display a lateral view of the embryos with anterior towards the left and dorsal up. For the final 
evaluation of the fluorescence assessment methods, 3 independent experiments were 
performed, respectively.  
 
The development of the fluorescence endpoint analysis methods and the image analysis was a 
major task of this thesis and is therefore described in the results section (chapter 3. 1). 
 
2. 8 Real-time quantitative PCR 
The question was raised whether the quantification of target gene expression could further 
increase the sensitivity of the zFET. With gene expression analysis, it was also envisaged to 
validate the morphological effects, which were detected via fluorescence microscopy. In 
particular the linkage between the phenotypic effects, which were detected in the transgenic 
lines, alterations in gene expression levels were aimed to be established. 
 
Total RNA was extracted from control and treated embryos 48 hpf using an optimized Trizol-
method: Total RNA was isolated from frozen, pooled embryos by homogenization in TRI-
Reagent (T9424, Sigma-Aldrich) using motor-driven plastic pistils. After centrifugation, 
RNA extraction with chloroform and ethanol and purification using RNeasy Mini Spin 
Colums (QIAGEN, Hilden, Germany) were performed according to manufactures’ protocols. 
RNA was then stored at – 80°C until further analysis. RNA concentration was measured using 
a Nanotrop 1000 spectrophotometer (Thermo Fisher Scientific, Schwerte, Germany). All 
further processed RNA samples had RNA integrity at 260/280 absorbance between 1.8 and 
2.2. These RNA samples were then diluted in RNase-free, DEPC-treated water and DNAse I 
(Sigma-Aldrich, AMP-D1) digested according to manufacturer’s instructions. I used 50 ng of 
total RNA for cDNA synthesis with Superscript III (Invitrogen, Carlsbad, USA). Real time 
quantitative PCR using SYBRGreen (BioRad®, Hercules, CA, USA; SYBR®GreenER qPCR 
SuperMix, Invitrogen) was performed on a BioRad iQ5 cycler (94°C for 3 min, 35 cycles: 
94°C for 45 sec, 59°C for 30 sec, 72°C for 30 sec; 72°C for 10 min) using primers specific to 
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following gene transcripts: fli1a (friend leukaemia integration1) forward primer 5’-
ggtgaacgtcaagcgagagt-3’; reverse primer 5’-atggcccagtctaaccactg-3’, cdh5 (VE- cadherin) 
forward 5’-tgcgtatgaggaaacacgac-3’; reverse 5’-cagctttgcaaggacaacaa-3’, flt4 (fms-related 
tyrosin kinase 4) forward 5’-caggatgagagcaccagaca-3’; reverse 5’-agcttgtgagaagccatcgt-3’ 
and gfap (glial fibrillary acid protein) forward 5’-gccgagctgaaccagctgaggg-3’; reverse 5’-
tgccgcagggcagtctcgtc-3’. 
The specific primers were designed using the web-based NCBI PrimerBlast tool 
(www.ncbi.nlm.nih.gov/tools/primer-blast). I used the housekeeping genes 18s and rpl8 as 
internal standards and a negative control without cDNA template was run with every assay to 
assess overall specificity. Q-PCR cycling conditions were 95°C for 8 min, for amplification 
40 cycles of 95°C for 15 s, 59°C for 30 s, 60°C for 30 s, followed by 95°C for 1 min, 55°C 
for 1 min and 55°C for 10 s. Relative expression ratio was calculated according to the 2 ∆∆Ct 
method (Paffl, 2004). RT-QPCR analysis was done with samples of three independent 
experiments. 
 
2. 9 Statistics 
All experiments were independently repeated three times and means were calculated for 
comparison. The statistical analyses were performed with GraphPad Prism (version 4.0b). For 
normally distributed data (D’Agotino and Pearson omnibus normality test), one-way ANOVA 
and Dunnett’s post-hoc test for multiple comparisons were performed. For non-normally 
distributed data, the Students t-test and Man-Withney test were performed. Significant 
differences to the controls and the corresponding significant levels are indicated by asterisks 
(*p<0.5; **p<0.01; ***p<0.001). 
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3. Results 
Different fluorescence markers were used to visualize the vascular system, the neural tube 
and the muscle morphology as well as apoptotic cells in the zebrafish embryo, which 
were otherwise not visible in conventional bright field microscopy. Analysis methods for 
these morphological structures were developed and quantifiable fluorescence endpoints 
were defined. This will be described in detail in the following sub-chapter (chapter 3. 1). 
Subsequently in sub-chapter 3. 2, the applicability of these fluorescence endpoints and their 
potential for detecting and evaluating chemical-induced effects were investigated in a proof-
of-principle study. The comparison of all bright field and fluorescence assessment 
endpoints is then presented in s u b - chapter 3. 3. Finally, the results of the gene expression 
analysis are shown (3.4). 
 
3. 1 Establishment of fluorescence-based toxicity assessment 
methods and test endpoints 
For the detection of vascular, neuronal and myotomal effects as well as change in the 
apoptosis rate fluorescent endpoints were assessed on the basis of image analysis. For each 
endpoint, a suitable morphological region within the embryo had to be defined to make the 
analysis most meaningful. Another important aspect that was taken into account when 
defining the analysis regions (= region of interest (ROI)) was the potential automation of 
the image analysis. The fish embryos were mounted laterally for easy analysis. The analysis 
was confined to the trunk section of the embryos including tail (Fig. 6). The region of the yolk 
sac was excluded from the analysis due to high auto-fluorescence. Endpoint analysis was 
conducted using full-focused images, which were assessed depending on the ROI and the 
corresponding fluorescence endpoint, as described as follows. 
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Fig. 6: Sketch of a zebrafish embryo 48 hpf, showing the regions of interest (ROIs) for the image analysis 
of the fluorescence microscopy. 
For image analysis of the fluorescence endpoints, the regions of interest (ROI) were confined to the trunk and 
tail of the zebrafish embryo. Frame 1 (dark blue frame) indicates the ROI of the endpoints ISV-defects and ISV-
length and angle between two hemi-segments. Frame 2 (green frame) indicates the ROI of the endpoints 
fluorescence intensity in the neural tube and the number of fluorescent cells). DA, dorsal aorta; PCV, posterior 
cardinal vein. 
 
 
3.1.1 Vasotoxicity endpoint 
To assess toxic effects on ISV development, eight blood vessels in the region above the yolk 
sac extension were evaluated for defects in each individual embryo of the Tg(fli1:EGFP)y1 
line. Defects of the ISVs were classified according to the following criteria: truncated, looped, 
missing, irregularly branched. The individual defects were recorded when present (yes and no 
answer). Concentration-response relationships were established and EC50 values derived. For 
simplification, this qualitative effect evaluation was defined as ISV fluorescence assessment, 
ISVFA.  
In a second step of the analysis, the lengths of the ISVs were determined. To account for 
biological interindividual size variation, the individual ISV-length measurements were 
normalized by calculating the ratio between the vessel length and the trunk width (dorso 
ventral axis), thereby obtaining the relative ISV-length (Fig. 7 C). To measure the vessel 
length, the tracing tool of the ImageJ Plugin NeuronJ was used (violet line). The trunk width 
in the area of each ISV measured was determined with the segmented line tool (blue line; Fig. 
7 B). An average relative ISV-length across all control embryos at 24 hpf was determined 
45% of the torso width and 80% at 48 hpf. Since the ISV-length is smaller than the trunk 
width, the calculated relative ISV-lengths remained <100% for the 48 hpf control embryos 
even though the ISVs had reached the maximum length. I therefore decided to set the relative 
ISV-length of untreated embryos at 48 hpf to 100%, and all other ISV-lengths were set in 
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relation to the control. The image section provided by the microscope enabled a convenient 
observation of eight ISVs independent of the lateral embryo orientation (horizontal or 
vertical). Furthermore, the measurement of more than eight vessels resulted in statistically 
imprecision, as even in control embryos the ISVs become shorter with the progression of the 
tail region. Therefore, eight vessels/embryo were analyzed of 3 – 5 individual embryos per 
treatment to ensure significance validity.  
 
 
Fig. 7: Blood vessels of control Tg(fli1:EGFP)y1 embryos (A) and image analysis of the relative ISV-length 
by comparison of the vessel length and trunk width (B + C) (methods 2. 4 and 2. 7).  
(A) Fluorescence full-focused images of the EGFP signal in the trunk of Tg(fli1:EGFP)y1 embryos at 24 hpf 
(upper panel) and 48 hpf (lower panel). (B) Images were processed by ImageJ into inverted black and white  
images, which were used for measuring the relative ISV-length of 24 and 48 hpf embryos. Therefore, individual 
vessel lengths (violet lines) were measured with a tracing tool of NeuronJ (plugin of ImageJ) and the trunk width 
(blue line), which was determined between the dorsal margin of the yolk sack extension (24 hpf) respectively the 
PCV (48 hpf) and the dorsal body back in the area of every ISV with the segmented line tool of ImageJ. The 
ISV-length and trunk width were measured for 8 ISVs per embryo. (C) For analysis of the normalized vessel 
development, the relative ISV-length was calculated by the ratio of vessel length and trunk width, which is 
shown by the formula. Images were obtained by standard fluorescence microscopy. All panels are oriented with 
anterior towards the left. DA, dorsal aorta; DLAV, dorsal longitudinal anastomic vessel; PCV, posterior cardinal 
vein; ISV, intersegmental vessel. Scale bar: 50 µm. 
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3.1.2 Neurotoxicity endpoint 
The GFP signal of Tg(gfap:GFP) embryos is confined to the CNS, where the neural tube 
shows consistent GFP intensity, which can decrease with chemical exposure. The neural tube 
has a clearly defined, unstructured shape compared to the ISVs. Hence, I selected no 
dimensional measurement but the overall fluorescence intensity of the neural tube as an 
endpoint for detecting chemical-induced defects.  
 
Fig. 8: Image analysis of the fluorescence intensity of the neural tube in Tg(gfap:GFP) embryos 48 hpf 
with ImageJ (methods: 2. 4 and 2. 7).  
(A) Fluorescence full-focused image of the trunk of Tg(gfap:GFP) control embryo and embryo exposed to 1.4% 
(v/v) ethanol after 48 h (method: 2.3). Images were obtained by standard fluorescence microscopy always under 
the same settings: exposure 1.3 sec., gain 1.6 and intensity 5. (B) For analysis of the fluorescence intensity the 
obtained images were not further processed. With the ImageJ polygon-working tool (yellow line) the region of 
interest (ROI) of the neural tube was selected and the integrated density (IntDen = fluorescence intensity) was 
measured. Anterior is towards the left in all panels. Scale bar: 100 µm. 
 
 
For the assessment of chemical effects on RGCs, the Tg(gfap:GFP) embryos were 
photographed always using the same microscopic settings (exposure: 1.3 sec; gain: 1.6; 
intensity: 5), and the obtained full-focused images were not further processed. This was to 
ensure direct comparability of fluorescence intensity values between different fish. For 
measurement, the ROI was selected with the polygon selection tool (Fig. 8 B). The 
fluorescence intensity was then determined as integrated density/area (IntDen/area) in ImageJ. 
The integrated density determines the ratio of the area and the mean gray value, i.e., the sum 
of the gray-values of all pixels within the ROI. Readings were provided as percentages of 
control density. Therefore, the mean integrated density/area of all untreated embryos at 48 hpf 
was defined as 100%, and all the other integrated density/area values were set in relation to 
the control.   
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3.1.3 Myotoxicity endpoint 
For the analysis of the muscle morphology of zebrafish embryos, whole-mount 
immunostainings with monoclonal antibody F59 were performed as described in chapter 2. 5. 
Zebrafish embryos have slow, tonic skeletal muscle fibers (red), which are active during slow 
swimming and fast, twitch muscle fibers (white), which are active during fast swimming 
(Buss and Drapeau, 2002). The secondary fluorescent antibody binds the antibody F59, which 
is specific to myosin and adaxial muscle cells and stains the red muscle fibers in zebrafish 
(see methods 2. 5). This enabled the detection of muscle abnormalities such as truncated 
fibers, disorganized fibers and altered angles between dorsal and ventral hemi-segments of 
myotomes caused by chemicals (Sylvain et al., 2010). In normally developed embryos both 
hemi-segments stand in a defined angle to each other and an aberration indicates disruption of 
embryogenesis thus, a teratogenic effect (Sylvain et al., 2010). Hence, I selected the angle 
between the two hemi-segments of somites to be measured to identify chemicals impacting on 
muscle morphology. 
 
 
Fig. 9: Image analysis of whole-mount immunostaining with antibody F59 of the muscle morphology in 
zebrafish embryos 48 hpf with ImageJ (methods: 2. 5 and 2. 7). 
(A) Detailed sketch of the zebrafish embryo somite structure. The myotomal segment is composed of two hemi-
segments, the dorsal and ventral myoseptum, which are innervate by organized muscle fibers. (B) Full-focused 
images of zebrafish embryos 48 hpf stained with specific monoclonal antibody against myosin (F59) after no 
exposure (control) and 1% (v/v) ethanol exposure (method: 2. 3), obtained by fluorescence microscopy. With the 
help of the angle tool of ImageJ the angle between the two hemi-segments of 4 segments was measured. Anterior 
is towards the left in all panels. Scale bar: 50 µm.  
 
 
To assess defects of the myotome, 3 – 5 embryos per treatment were laterally photographed 
(z-stack images). The generated full-focused images were not further processed and directly 
used to measure the angle between the dorsal and ventral hemi-segment. It has been proven 
that in control embryos the values of the angles between the hemi-segments were only 
constant in the region above the yolk sack extension. Hence, the angles of 3 – 5 randomly 
chosen segments above the yolk sac extension were measured as it is demonstrated in figure 9 
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B. The angle between the two hemi-segments of normally developed 48 hpf zebrafish 
embryos was around 98° – 100° (Fig. 9 B).  
 
3.1.4  Apoptosis endpoint 
Apoptotic cells were visualized by acridine orange staining and analyzed in full-focused 
images of 3 – 5 embryos per treatment. To discriminate the fluorescent cells from background 
fluorescence, a threshold was manually set for each picture (Fig. 10 B). The threshold is used 
to classify image points as objects and to distinguish between focused pixels or background 
(noise signals) according to their intensity values (Gerlich et al., 2003), resulting in binarized 
images. After conversion into binary images, the region of the trunk and tail without the yolk 
sac extension was selected as ROI using the polygon tool of ImageJ (Fig. 10 C). The 
fluorescent (apoptotic) cells were counted with the tool ‘Analyze Particles’ after defining 
‘Outlines’ additionally to the default settings. This approach enables counting of small single 
fluorescent cells (Fig. 10 D). In control embryos, the amount of apoptotic cells was 27 (± 2) 
cells per region of interest (ROI).  
In case of a high density of substance-induced apoptotic cells, I measured the integrated 
density of the converted binary images. Using the polygon tool of ImageJ, the same region of 
the trunk and tail without the yolk sac extension, like in the cell counting, was selected as 
ROI. The integrated density/area (IntDen/area) of 3 – 5 embryo per exposure were measured 
(see 3.1.2: Neurotoxicity endpoint). Measurements are presented as percentages compared to 
control. Whereas the mean integrated density/area of all untreated embryos at 48 hpf was 
defined as 100% and all the other integrated density/area values set in relation to the control. 
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Fig. 10: Image analysis of vital staining of apoptosis with acridine orange in zebrafish embryos 48 hpf 
with ImageJ (methods: 2. 6 and 2. 7).  
(A) Fluorescence full-focused image of wild type zebrafish embryos 48 hpf after no exposure (control) and 1.4% 
(v/v) ethanol exposure (method: 2.3), which were additionally stained with 2 µg/ml (w/v) acridine orange, 
respectively. (B) For analysis of the stained apoptotic cells, an individual threshold (red color) was manually set 
in ImageJ. (C) The images were converted into binary images, where the region of interest (ROI) was selected 
with the polygon tool (yellow line). After executing ‘analyze particles’ in ImageJ, the output of the number of 
particles (= fluorescent cells) was given, displayed as an image (D) and data table (not shown). The number of 
particles equals the number of apoptotic cells. Images were obtained by standard fluorescence microscopy. 
Anterior is towards the left in all panels. Scale bar: 100 µm.  
 
 
3. 2 Proof-of-principle study 
In a proof-of-principle study, exposure of triclosan, genistein and cartap in comparison to 
reference (control) chemicals (ethanol, SU4312 and pentoxifylline) were used to demonstrate 
the validity of the newly developed fluorescence endpoints. The toxicity of these chemicals 
was initially assessed with bright field microscopy (3.2.1) and subsequently analyzed 
applying the new fluorescence endpoints (3.2.2 - 3.2.5). In terms of ethical and economic 
reasons, I conducted the morphological bright field assessment (zFET) and the 
immunostainings, as well as the vasotoxicity assessment on Tg(fli1:EGFP)y1 embryos. The 
neurotoxicity assessment was done with Tg(gfap:GFP) and the apoptosis assessment with 
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wild type embryos. The vital staining of the apoptotic cells had to be performed on wild type 
embryos due to the overlapping fluorescence signals of the AO staining and the EGFP/GFP of 
the transgenic lines. Thus, I was able to gain a maximum amount of data with minimal 
number of animals. Additionally, it had contributed to minimize the time and effort of the 
assessment. 
  
3.2.1 Morphological phenotype determined by bright field microscopy  
For general toxicological characterization of the effects of ethanol, SU4312, triclosan, 
genistein, and cartap on zebrafish embryos, standard 48 h zFETs were conducted and assessed 
by bright field microscopy. For all substances, a concentration-dependent increase in the 
effects was established (Fig. 12 and Fig. 13). Zebrafish embryos exposed to ethanol, SU4312, 
triclosan, genistein and cartap displayed a broad range of morphological abnormalities 
compared to the normal phenotype (Fig. 12). In figure 12 are next to the mortality, sublethal 
effects decoded, which can be linked to substances’ vasotoxic potential (reduced blood 
circulation, edema), neurotoxic potential (malformation of notochord) and myotoxic potential 
(malformation of tail) after 48 h of substance exposure. The decoding of all sublethal effects 
after 24 h of exposure is not shown since they can not be directly correlated to the tissue-
specific toxicity classes, except of the endpoint no spontaneous movement. This effect is only 
recorded after 24 hpf and indicates a neurotoxic disruption (Irons et al., 2010), which is why it 
is additionally shown in figure 12. The summarized effects (lethal and sublethal) recorded 
after 24 h and 48 h of exposure can be found in figure 13. Typical effect phenotypes are 
depicted in figure 11. The results of the negative control of blood vessel development, 
pentoxifylline, are described separately in sub-chapter 3.2.2. 
The bright field analysis showed that ethanol mainly reduced blood circulation and caused 
pericardial edema at concentrations ≥ 0.71% (Fig. 12 A). I observed malformations of tail at 
the highest test concentration of 2% (v/v) ethanol only. The sum of all morphological effects 
determined by bright field microscopy is displayed in figure 13. Ethanol concentrations ≥ 
1.41% (v/v) caused significant effects compared to the control (p = 0.01) after 48 h of 
exposure (Fig. 13 A). Assessment of 24 h ethanol treatment was not recorded. 
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Fig. 11: Morphological phenotype of control and exposed 48 hpf-zebrafish embryos (method: 2. 3).  
Exemplary bright field micrographs of a normally developed control zebrafish embryo (A) and embryos 
displaying different effects due to exposure to nominal 1% (v/v) ethanol (B), 2.23 µM SU4312 (C), 1.93 µM 
triclosan (D), 12.43 µM genistein (E) and 0.67 µM cartap (F). Images were obtained by standard bright field 
microscopy. Live embryos were photographed in 96 well plates along their z-axis using the LAS-AF software of 
the Leica microscope. The obtained z-stacks were processed into full-focused images using ImageJ (methods 
analog to 2.7). The exposed embryos showed typically malformations of the heart and/or notochord and 
pericardial edema. Scale bar: 500 µm. 
  
 
The antiangiogenic control substance SU4312 caused a significant increase in 
morphologically impaired embryos from 1.44 µM after 24 h (p = 0.05) and 2.23 µM after 48 
h (p = 0.01) of exposure (Fig. 13 B). SU4312 exposure primarily caused coagulation of the 
eggs (mortality). The mortality increased with increasing concentration up to 39% at a 
concentration of 3.48 µM of SU4312 (Fig. 12 B). After 24 h, a significant 30% of embryos of 
the 1.44 µM treatment were coagulated and after 48 h the significance threshold was at 2.23 
µM corresponding to 52% of the exposed embryos. The most apparent effects associated with 
vasculo- and angiogenesis, i.e. reduced blood circulation and heart malformation, only 
occurred at higher test concentrations and did not exceed 20% of the embryos (Fig. 12 B). 
The highest SU4312 concentration of 3.48 µM affected 64% of the embryos.  
Triclosan and genistein caused a wide range of morphological effects. In triclosan-exposed 
embryos, I observed a reduced blood circulation, often in combination with blood 
accumulations in the tail, and malformations of the tail, as well as pericardial and yolk sac 
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edema at 48 hpf and a lack of spontaneous movement at 24 hpf (Fig. 12 C). Additionally, 
general growth retardation was recorded (Appendix 8. 1, Table 8). Lethal effects occurred 
after 48 h of exposure at a concentration of ≥ 2.45 µM, and at 2.76 µM 35% of the embryos 
were found dead. Cumulative effects showed significant differences to the control at 2.45 µM 
after 24 h of exposure (p = 0.05), and after 48 h of exposure at the highest test concentration 
of 2.76 µM (p = 0.01; Fig. 13 C).  
Genistein caused a strong induction of sublethal effect, whereas lethality was only observed 
in 28% of the embryos at the highest test concentration of 14.80 µM after 48 h of exposure 
(Fig. 12 D). A prominent sublethal effect was the malformation of tail, which occurred in 
88% of the embryos treated with 14.80 µM of genistein. Further, I detected reduced blood 
circulation and edema (Fig. 11 E). 48 h genistein treatment resulted in a significant 
impairment of zebrafish embryo development from a concentration of ≥ 10.47 µM (p = 0.01; 
Fig. 13 D). After 24 h of genistein exposure, only the highest test concentration of 14.80 µM 
caused a significant increase in embryos affected (p = 0.01), with 92% of embryos showing 
morphological abnormalities (Fig. 13 D). 
Cartap treatment mainly affected the notochord morphology (Fig. 11 F). At a concentration of 
0.55 µM, 8% of the embryos displayed a slightly undulating notochord. At cartap 
concentrations of 0.84 µM, 88% of embryos displayed severe notochord deformations (Fig. 
12 E). Additionally, loss of pigmentation was observed after 48 h (Annex 8. 1, Table 10). No 
effects on the blood circulation or heart morphology could be detected. After cartap exposure, 
fewer than 10% of the embryos died (Fig. 12 E). I determined significant morphological 
effects caused by cartap exposure (24 and 48 h) at concentrations of 0.67 and 0.84 µM (p = 
0.01; Fig. 13 E). 
The results demonstrated that all substances but cartap affected the blood circulatory system 
of the zebrafish embryos. 
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Fig. 12: Lethal and sublethal morphological effects occurring in zebrafish embryos exposed for 48 h to 
different concentrations of (A) ethanol, (B) SU4312, (C) triclosan, (D) genistein or (E) cartap (method: 2. 
3).  
Cumulative morphological effects according to OECD draft guideline (OECD TG 2006) and background paper 
of Braunbeck and Lammert (2006) were determined by microscopic bright field assessment (zFET; mean + SEM 
of 3 independent experiments with n = 21 – 50 embryos per concentration and experiment). Lethal effects 
(coagulation, no detachment of tail, no somites, no heartbeat and no differentiation) were summarized as 
mortality. Sublethal effects, which can be linked to substances’ vasotoxic potential: reduced blood circulation, 
edema; neurotoxic potential: no spontaneous movement at 24 hpf, malformation of notochord and myotoxic 
potential: malformation of tail, are displayed. All effects displayed were recorded after 48 h of exposure, except 
the observation no spontaneous movement at 24 hpf. This additional endpoint was included as it represents an 
apical effect, which typically indicates a neurotoxic potential.  
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Fig. 13: Summarized morphological effects in zebrafish embryos treated with (A) ethanol, (B) SU4312, (C) 
triclosan, (D) genistein and (E) cartap analysed by bright field microscopy (method: 2. 3).  
Concentration-dependent increase in the proportion of embryos showing any (cumulative of lethal and sublethal) 
morphological effects (%) after exposure to different substances for 24 and 48 h. Effects were determined 
according to OECD draft guideline (OECD TG 2006) and background paper of Braunbeck and Lammert (2006). 
Significant differences to the control are indicated with asterisks (mean ± SEM of 3 independent experiments 
with n= 21 – 50 embryos per concentration and experiment; *p<0.05, **p<0.01; one-way ANOVA with post-
hoc Dunnet’s multiple comparison test).  
 
 
3.2.2 ISV assessment of Tg(fli1:EGFP)y1 after triclosan, genistein and cartap 
exposure 
The utility of fluorescence endpoints for the microscopical evaluation of effects in the zFET 
was scrutinized in comparison to standard bright field microscopy. The vasotoxic potential of 
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triclosan, genistein and cartap was assessed qualitatively (ISV defects) and quantitatively 
(ISV-length). SU4312 and pentoxifylline were used as control compounds. The results of the 
negative control pentoxifylline are described separately. 
 
Comparison of the morphological bright field (MBFA) and the ISV fluorescence effect 
assessment (ISVFA)  
To evaluate the application of Tg(fli1:EGFP)y1 embryos for toxicity assessment, the MBFA 
was compared with the ISVFA in terms of sensitivity. As a benchmark to directly compare 
the two qualitative effect assessment methods, the effect concentration (EC) values for the 
MBFA and ISVFA were used. The EC50 values, obtained for each test substance, were used 
as estimates of the method’s sensitivity to indicate developmental toxicity. The concentration-
effect curves and the resulting EC50 values are displayed in figure 14. 
For the known vasotoxic control substance SU4312, a slight shift of the ISV concentration-
effect curve to the left along the x-axis was observed, resulting in a lower EC50 of 1.85 µM 
compared to the EC50 of 2.46 µM for the MBFA. Thus, a higher sensitivity for vasotoxicity 
was indicated (Fig. 14 A). For triclosan, a similar trend was found (Fig. 14 B), and the EC50 
value for ISVFA of 1.64 µM suggested a higher sensitivity of vascular than of general 
developmental toxicity effects (MBFA-EC50 of 2.16 µM). On the contrary, genistein 
displayed a slightly rightwards-shifted ISVFA concentration-effect curve, resulting in a 
minimally higher EC50 of 9.38 µM than for the MBFA (EC50 of 9.03 µM; Fig. 14 C). A 
tendency towards an equal or lower vasotoxic potential was therefore indicated. For cartap, 
the EC50 values of both assessment methods were 0.15 µM. Although, the concentration-
effect curves of morphological malformations in the MBFA showed a steeper slope than those 
of the ISV defects (Fig. 14 D). As a consequence, minimal changes in the concentrations of 
genistein and cartap led to big differences in the bright field morphology effect levels. Even 
though the EC50 values of genistein for both assessment methods were almost identical, the 
100% effect level of the MBFA was reached at a lower concentration of 12.43 µM than for 
the ISVFA, which reached 74% at the highest concentration of 14.80 µM (Fig. 14 C). Overall, 
for genistein and cartap a higher sensitivity of the ISVFA was indicated at lower 
concentrations, while at higher test concentrations, the MBFA was the more sensitive method. 
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Fig. 14: Concentration-effect curves and EC50 values of (A) SU4312, (B) triclosan, (C) genistein and (D) 
cartap, derived from 48 hpf morphological bright field assessment (MBFA) (blue) and ISV fluorescence 
assessment (ISVFA) (green) (methods: 2. 3 and 3.1.1).  
Leftward shift of the EC-curves indicates a more sensitive effect detection. Curves and EC50 values were 
calculated by probit analysis using ToxRat® Professional 2.10. Three independent experiments with n= 21 – 50 
embryos per concentration and experiment were merged for the calculation of the concentration-response curves 
based on the zFET (MBFA) and n=40 – 56 ISVs per concentration and experiment for the calculation of the 
dose-response curves based on the ISV defects assessment (ISVFA).  
 
 
Intersegmental vessel (ISV) length enables effect quantification 
The relative length of the ISVs in dependence to substance concentration was determined to 
evaluate the vasotoxic potential of the substances and to obtain a quantitative test endpoint 
additionally to the ISVFA (defect assessment and corresponding effect threshold 
determination).  
In accordance with the literature, SU4312 exposure inhibited the angiogenic vessel growth 
and specifically blocked the ISV outgrowth in the zebrafish embryos. I observed truncation of 
the ISVs with increasing concentration until a complete lack of ISVs occurred as a final stage. 
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Embryos exposed to SU4312 showed a decrease in the ISV-length compared to untreated 
embryos already at 24 hpf (Fig. 15 A and Fig. 16 A). There, I observed a significant 
difference at a SU4312 concentration of 0.61 µM (p = 0.05). Fig. 15 A shows images of 
truncated ISVs in 48 hpf embryos exposed to low (0.91 µM) and high (3.48 µM) 
concentrations of SU4312. At this time point, a significant increase in ISV developmental 
defects was observed also at a SU4312 concentration of 0.61 µM, which resulted in a 10% 
reduced ISV-length (Fig. 16 A). At 3.48 µM of SU4312, the mean relative ISV-length was 
58% of control. 
The patterns of the ISV effects in embryos exposed to triclosan were inconsistent and variable 
between individuals of the same treatment. In some embryos, triclosan exposure caused 
truncated and missing ISVs while in others it resulted in diffuse EGFP-signals, independently 
of the applied concentration. Fig. 15 B shows an embryo treated with 2.76 µM of triclosan, 
where no clear ISV-structure was detected. The ISVs appeared disrupted, as did the EGFP 
signal. However, I determined significant differences in the relative ISV-length (Fig. 16 B). 
After 24 h of triclosan exposure, a significant decrease in the ISV-length compared to the 
controls was observed from ≥ 1.73 µM (p = 0.01), but further concentration increase did not 
result in further decrease in the relative ISV-length. Relative ISV-lengths of between 46 – 
50% were measured for these triclosan concentrations. After 48 h of triclosan exposure, only 
the two highest concentrations of 2.45 µM and 2.76 µM had significant effects on the ISV 
development (p = 0.001), reducing the relative ISV-lengths to 62 and 64%, respectively (Fig. 
16 D). In genistein-exposed embryos, I observed smaller vessels and irregularities in the 
spacing between the ISVs (Fig. 15 C). All ISVs appeared thinner and with increasing 
concentration, also the degree of truncations and malformations increased. Consequently, the 
relative ISV-length decreased with increasing genistein concentration and exposure time (Fig. 
16 C). The 24 hpf assessment showed no effects on ISV development for the first three 
concentrations. At a concentration of 12.43 µM, the differences in ISV-length became 
significant (p = 0.01), with the relative ISV-length reaching 28%. After 48 h of genistein 
exposure, significant ISV-length differences (p = 0.001) were caused by all concentrations, 
starting from 7.4 µM with a relative ISV-length of 81% (Fig. 16 D). 
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Fig. 15: Phenotype of the intersegmental blood vessels (ISVs) of Tg(fli1:EGFP)y1 embryos at 48 hpf after 
exposure to different substances (methods: 2. 7 and 3.1.1) .  
Images showing EGFP expression in the ISV of Tg(fli1:EGFP)y1 embryos exposed to increasing concentrations 
of (A) SU4312 (0.91 and 3.48 µM), (B) triclosan (1.93 and 2.76 µM), (C) genistein (7.40 and 14.80 µM) and (D) 
cartap (0.55 and 0.84 µM) (method: 2. 3). ISVs show irregularities and an aberrant morphology (indicated by 
arrowheads). Images were obtained by standard fluorescence microscopy. Anterior is towards the left in all 
panels. Scale bar: 50 µm.  
 
 
Embryos exposed to cartap displayed a characteristic ISV-phenotype, which was in 
accordance with published results (Zhou et al., 2009). ISVs were often looped and irregularly 
branched (Fig. 15 D), and a straight trajectory of the ISVs from the ventral to dorsal axis 
instead of the characteristic S-pattern was typically observed. The straightness of the ISVs 
caused a decrease in the relative ISV-length down to 72%, but did not decrease further with 
increasing cartap concentrations (Fig. 16 D). For the 24 hpf assessment point, I observed only 
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concentration-independent changes in the relative ISV-length, mainly displayed by ISV-
spacing irregularities. At 48 hpf significant abnormalities in ISV development occurred from 
a concentration of 0.55 µM (p = 0.001).  
 
 
Fig. 16: Concentration-dependent effects on intersegmental blood vessel (ISV) development and growth of 
Tg(fli1:EGFP)y1 embryos after treatment with different substances (method: 3.1.1).  
Measurement of the relative ISV-length (%) after 24 and 48 h of exposure to (A) SU4312, (B) triclosan, (C) 
genistein and (D) cartap (method: 2. 3). Significant differences of the ISV-length to the control group are 
indicated (mean ± SEM of 3 independent experiments; 8 ISVs of 3 – 6 embryos per concentration and 
experiment were measured with ImageJ and NeuronJ; *p<0.05, **p<0.01, ***p<0.001; one-way ANOVA with 
post-hoc Dunnet’s multiple comparison test).  
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Negative control substance pentoxifylline induced systemic embryo toxicity  
Pentoxifylline was tested as a negative control substance for vascular defects, as it is known 
to improve blood flow by increasing the flexibility of the erythrocytes and leukocytes (Bessler 
et al., 1986; Semmler et al., 1993). However, 48 h exposed zebrafish embryos showed slow 
blood circulation at concentrations ≥ 593.22 µM. Besides, malformations of the heart and the 
notochord occurred in the two highest exposure concentrations (Fig. 17 B). Pericardial and/or 
yolk sac edema were also recorded in pentoxifylline treated embryos (Appendix 8. 1, Table 
7). The cumulative EC50 for all morphological effects (MBFA) at 48 hpf was 395.66 µM 
(Fig. 17 C). A concentration-response curve for ISVFA could not be established since the 
cumulative effect level did not exceed 25% within the range of concentrations tested. No 
significant impairment of the ISV development was observed in all but the highest test 
concentration. At nominal 1019.44 µM few embryos showed some effects on the ISV 
development, reducing the relative ISV-length to 90.1% (Fig. 17 D). Thus, a very weak 
response of the ISV development was detected, most likely as a secondary effect of the 
general toxicity caused by the highest pentoxifylline concentration. 
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Fig. 17: Effects of exposure of zebrafish embryos to negative control pentoxifylline assessed by bright field 
(A+B) and fluorescence microscopy (D) (methods: 2. 3 and 3.1.1).  
(A) Proportion of embryos (%) with morphological effects in total per treatment after 24 h and 48 h exposure of 
pentoxifylline (mean values ± SEM of 3 independent experiments with 24 – 51 embryos. (B) Percentage of 
embryos exhibiting specific effects (reduced blood circulation (b), malformation of heart (mh) or malformation 
of notochord (not)) after 48 h of increasing pentoxifylline concentrations. (C) Comparison of concentration-
effect curves and EC50 values (probit analysis using ToxRat® Professional 2.10), based on morphological bright 
field assessment (MBFA) (blue) and ISV fluorescence assessment (ISVFA) (green) after 48 h. Data of 3 
independent experiments with n= 24 –51 embryos each were pooled for the calculation of the MBFA- and n= 40 
– 56 ISVs each for the calculation of the ISVFA-concentration-response curves. (D) Relative ISV-lengths (%) 
compared to the controls measured in Tg(fli1:EGFP)y1 embyos after 48 h of exposure (mean values ± SEM of 3 
independent experiments; 8 ISVs of 3 – 6 embryos per concentration). Significant differences are indicated by 
asterisks (*p<0.05, **p<0.01, ***p<0.001; one-way ANOVA with post-hoc Dunnett’s multiple comparison 
test). 
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3.2.3 Fluorescence intensity of Tg(gfap:GFP) embryos as a measure of 
neural development effects  
The GFP expression of Tg(gfap:GFP) embryos 48 hpf enabled the visualization of the neural 
tube, as shown in fFig. 18. The fluorescence intensity in the neural tube was dependent of the 
chemical treatment, which can also be seen in Fig. 19, depicting the measurement values 
against the treatment concentrations. 
 
 
Fig. 18: Fluorescence signal in the trunk of Tg(gfap:GFP) embryos 48 hpf after exposure to different 
substances (methods: 2. 7 and 3.1.2). 
Images showing GFP expression in radial glial cells and astrocytes present in the neural tube of Tg(gfap:GFP) 
embryos treated with (A) positive (0.5 and 1.4% (v/v) ethanol) and (B) negative control (0.61 and 1.44 µM 
SU4312). (C) GFP expression in the neural tube of Tg(gfap:GFP) embryos exposed to increasing concentrations 
of triclosan (1.73 and 2.45 µM), (D) genistein (8.81 and 12.43 µM) and (E) cartap (0.42 and 0.84 µM) (method: 
2. 3). Reduced GFP expression, resulting in decreased fluorescence intensity, indicates a neurotoxic potential of 
the substance. Images were obtained by standard fluorescence microscopy. Anterior is towards the left in all 
panels. Scale bar: 250 µm. 
 
 
Ethanol is known to act as a neurotoxin (Muth-Köhne et al., 2012; Zhang and Gong, 2013) 
and was thus used as positive control for the assessment of GFAP expression alterations. As 
expected, ethanol impaired the development of the RGCs in the zebrafish embryo, resulting in 
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a concentration-dependent decrease of the fluorescence intensity (Fig. 18 A and Fig. 19 A). 
Already 0.5% (v/v) of ethanol caused a significantly decreased fluorescence intensity of 28% 
(p = 0.01) compared to control embryos. For the highest tested ethanol concentration of 2% 
(v/v), only 6.6% (v/v) of the maximum fluorescence signal remained.   
 
 
Fig. 19: Fluorescence intensity [%] of GFP in the neural tube of Tg(gfap:GFP) zebrafish embryos 48 hpf 
exposed to different chemicals (method: 3.1.2). 
Fluorescence intensity after exposure to (A) positive control ethanol, (B) negative control SU4312, (C) triclosan, 
(D) genistein and (E) cartap (method: 2. 3). Significant differences in the fluorescence intensity [%] to the 
control group are indicated (mean ± SEM of 3 independent experiments; Fluorescence intensity/ROI of 5 – 6 
embryos per concentration and experiment was measured with ImageJ; *p<0.05, **p<0.01; one-way ANOVA 
with post-hoc Dunnett’s multiple comparison test).  
 
 
In addition to ethanol, genistein showed a concentration-dependent impact on the 
fluorescence intensity in the neural tube (Fig. 18 D and Fig. 19 D). Significant effects 
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compared to the control were assessed from a genistein concentration of 10.47 µM (p = 0.05), 
which resulted in a remaining fluorescence intensity of 20.5% at 14.80 µM (p = 0.01). This 
corresponded to a loss of the fluorescence signal of 79.5% (Fig. 19 D). With the exception of 
the highest triclosan concentration, triclosan and cartap had no effect on the fluorescence 
intensity of the neural tube of zebrafish embryos (Fig. 19 B, C, E), although an aberrant 
morphology of the neural tube was observed (Fig. 18 C+E). 
 
3.2.4 Angle aberrations between myotome hemi-segments indicate effects 
on muscle morphology 
The impact on the muscle fiber morphology was analyzed by whole-mount immunostainings 
and measurments of the angle between the hemi-segments as shown in Fig. 21. The image 
analysis showed disorganized muscle fibers in embryos exposed to high concentrations of 
ethanol, triclosan and genistein (Fig. 20 A, C, D). Severe aberrant muscle fibers were 
observed in particular in the embryos exposed to genistein (Fig. 20 D).  
Ethanol was used as positive control, as it was described by Sylvian et al. (2010) to cause 
severe effects on myotome development. In the present study, an increase in the mean angle 
between the hemi-segments with increasing concentrations of ethanol, genistein and cartap 
was determined (Fig. 20 A, D, E and Fig. 21 A, D, E). SU4312 and triclosan had some but no 
concentration-dependent impact on the muscle morphology (Fig. 21 B+C). Ethanol caused 
significant effects on the muscle morphology from concentrations ≥ 0.71% (v/v) (p = 0.01 – 
0.001). A mean angle of 106° (± 1.6°) between the hemi-segments in embryos treated with 
2% (v/v) of ethanol was measured. Genistein-exposed embryos showed an increase in the 
angle between the hemi-segments up to 123° (± 1.8°), with significant differences compared 
to the control from 10.47 µM (p = 0.01; Fig. 21 D). Zebrafish embryos exposed to cartap 
showed significant myotomal effects at the two highest test concentrations of 0.67 µM (110° 
± 1.9°; p = 0.01) and 0.84 µM (116° ± 2.4°; p = 0.001) (Fig. 21 E). 
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Fig. 20: Muscle morphology of zebrafish embryos 48 hpf, whole-mount immunostained with monoclonal 
antibody F59 after exposure to different substances (methods: 2. 5, 2. 7 and 3.1.3).  
Images showing representative angles between hemi-segments of exposed embryos to (A) positive (0.5 and 
1.4% (v/v) ethanol) and (B) negative control (0.61 and 1.44 µM SU4312). (C) Muscle morphology of embryos 
exposed to increasing concentrations of triclosan (1.73 and 2.18 µM), (D) genistein (10.47 and 14.80 µM) and 
(E) cartap (0.42 and 0.67 µM) (method: 2. 3). The fluorescence signal of the secondary antibody DyLightTM 
(549-conjungated) and the binding specificity of the primary antibody F59 against myosin and axial muscle cells 
visualized the muscle fibers in the fixed embryos. The angle between the two hemi-segments was measured with 
the angle tool of ImageJ. If the angle between two hemi-segments increases to ≥100°, a chemically induced 
myotoxic effect was indicated. Disorganization of fiber morphology is marked by arrowhead. Images were 
obtained by standard fluorescence microscopy. Anterior is towards the left in all panels. Scale bar: 50 µm.  
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Fig. 21: Mean angles between hemi-segments [°] of myotome segments of zebrafish embryos 48 hpf after 
exposure to different chemicals (methods: 2. 5 and 3.1.3). 
Effects on muscle morphology after exposure to (A) positive control ethanol, (B) negative control SU4312, (C) 
triclosan, (D) genistein and (E) cartap (method: 2. 3). Measurements of the mean angle between hemi-segments 
were provided by the image analysis of the whole-mount immunostainings with F59. Significant differences of 
the mean angle between hemisegments [°] to the control group are indicated (mean ± SEM of 3 independent 
experiments; 3 – 5 angles of hemi-segments of 3 – 6 embryos each per concentration and experiment were 
measured with ImageJ; *p<0.05, **p<0.01, ***p<0.001; one-way ANOVA with post-hoc Dunnett’s multiple 
comparison test). 
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3.2.5 Impact on apoptosis  
The vital staining with AO provided information on the chemical-induced impact on the 
apoptosis rate in zebrafish embryos. Ethanol and genistein increased apoptosis in 48 hpf 
zebrafish embryos, as shown in figure 22 (A+D) and Fig. 23 (A+D). The apoptotic cells in 
embryos exposed to genistein occurred abundantly in the region of the neural tube (Fig. 22 
D). Ethanol-induced apoptotic cells were less frequent and more scattered across the trunk 
region (Fig. 22 A).  
 
Fig. 22: Trunk region of zebrafish wild type embryos 48 hpf, vital stained with acridine orange after 
exposure to different substances (methods: 2. 6, 2. 7 and 3.1.4).  
(A) Images showing the fluorescent acridine orange (AO) staining of apoptotic cells in the trunk region of 
zebrafish embryos exposed to positive (0.5 and 1.4% (v/v) ethanol) and (B) negative control (0.61 and 1.44 µM 
SU4312). (C) Fluorescent, i.e. apoptotic cells in the trunk region of embryos treated with 1.73 and 2.45 µM 
triclosan, (D) 8.81 and 12.43 µM genistein and (E) 0.42 and 0.67 µM cartap (method: 2. 3). AO staining enabled 
the detection of chemically induced apoptosis: number of apoptotic cells increased with increasing exposure 
concentrations of ethanol and genistein. Images were obtained by standard fluorescence microscopy. Anterior is 
towards the left in all panels. Scale bar: 250 µm.  
 
 
I determined an increase in the number of apoptotic cells in the ROI of zebrafish embryos 
exposed to ethanol, triclosan and genistein (Fig. 23 A, C, D). Triclosan caused a slight 
concentration-dependent increase in apoptotic cells at concentrations ≥ 2.45 µM with up to 95 
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(± 21) apoptotic cells/ROI (p = 0.01, Fig. 23 C). Ethanol and genistein showed a stronger 
influence on apoptosisas, as 176 (± 32) apoptotic cells/ROI were counted in embryos exposed 
to 2% (v/v) ethanol and 151 (± 31) apoptotic cells/ROI in embryos exposed to 8.81 µM 
genistein (Fig. 23 A+D).  
In case of a dense accumulation of apoptotic cells, another assessment method had to be 
applied since counting of individual cells was not possible anymore. This alternative 
assessment method was compared to the cell counting (see sub-chapter 3.1.4).  
By measuring the area-wide fluorescence intensity in the ROI, effects were determined in 
embryos treated with ethanol and genistein (Fig. 24 A+D). A significantly increased 
fluorescence intensity was determined for genistein at concentrations ≥ 10.47 µM (p = 0.05), 
increasing with concentration (Fig. 24 D). In contrast to the fluorescent cell counting, the 
area-wide fluorescence intensity of ethanol-exposed embryos determined significant effects 
only in the highest test concentration of 2% (v/v) ethanol (p = 0.05, Fig. 24 A). The apoptotic 
impact of triclosan was too minimal to be detected by measuring the fluorescence intensity of 
the ROI (Fig. 24 C). SU4312 and cartap had no effects on apoptosis, independently of the 
assessment method (Fig. 23 B+E).  
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Fig. 23: Number of apoptotic cells in the trunk region of acridine orange (AO) stained zebrafish embryos 
48 hpf exposed to different chemicals (methods: 2. 6 and 3.1.4). 
The number of fluorescently labeled cells present in the trunk region (= ROI: region of interest) of exposed 
embryos was assessed by the ImageJ tool Analyze particles, counting individual single apoptotic cells. The 
embryos were exposed to different concentrations of (A) ethanol (positive control), (B) SU4312 (negative 
control), (C) triclosan, (D) genistein and (E) cartap (method: 2. 3). Significant differences in the number of 
fluorescent cells/ROI to the control group are indicated (mean ± SEM of 3 independent experiments; number of 
fluorescent cells/ROI of 3 – 4 embryos per concentration and experiment was measured. *p<0.05, **p<0.01; 
one-way ANOVA with post-hoc Dunnett’s multiple comparison test).  
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Fig. 24: Fluorescence intensity [%] in the trunk region of acridine orange (AO) stained zebrafish embryos 
48 hpf exposed to different chemicals (methods: 2. 6 and 3.1.4). 
The fluorescence intensity (IntDen/area) of the trunk region (= ROI: region of interest) of the same embryos, 
which were used for the counting of fluorescent cells (Fig. 23) was assessed. The embryos were exposed to 
different concentrations of (A) ethanol (positive control), (B) SU4312 (negative control), (C) triclosan, (D) 
genistein and (E) cartap (method: 2. 3). Significant differences of the fluorescence intensity [%] to the control 
group are indicated (mean ± SEM of 3 independent experiments; Fluorescence intensitiy/ROI of 3 – 4 embryos 
per concentration and experiment was measured. *p<0.05, **p<0.01; one-way ANOVA with post-hoc Dunnett’s 
multiple comparison test). 
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3. 3 Comparative evaluation of the microscopic bright field and 
fluorescence endpoints  
To evaluate the specificity and sensitivity of the toxicity analysis using the two different 
microscopic assessment methods, all 48 h non-fluorescence endpoint (A) and newly 
established fluorescence endpoint data (B – F) were contrasted in Fig. 25. For an easy 
comparison of the response and sensitivity of each method, frames (red and green) were 
included indicating the significant effect thresholds. 
Ethanol exposure caused significant effects for all tested endpoints. It resulted in significant 
vaso- and neurotoxicity effects already at the lowest test concentration of 0.5% (v/v), as 
determined by the image analysis of the corresponding transgenic lines (Fig. 25 B+C). The 
results of the SU4312 exposure confirmed the specific inhibition of the VEGF pathway, as 
only the MBFA and the ISV-length assessment showed significant and concentration-
dependent effects (Fig. 25 A+B). The ISV-length was more sensitive, indicating significant 
effects already at the second test concentration (0.61 µM). 
The results of the triclosan treatment revealed significant effects for the ISV-length 
assessment and for apoptosis at a concentration of 2.45 µM (Fig. 25 B and Fig. 25 E+F). For 
the MBFA significant effects were detected only at 2.76 µM (Fig. 25 A). The only substance, 
which showed concentration-dependent effects in all tested endpoints in this study, was 
genistein. However, the vasotoxicity endpoint responded most sensitive at a test concentration 
of 7.4 µM (Fig. 25 B). In contrast, cartap caused an effect response only for MBFA and the 
vaso- and myotoxicity endpoints, with the ISV-length assessment being the most sensitive 
endpoint (significant from 0.55 µM) (Fig. 25 A, B, D). Significant effects on the angle 
between the two hemi-segments occurred at the same concentration as the cumulative 
morphological effects (0.67 µM).  
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Fig. 25: Summary of bright field (A) and fluorescence endpoint data (B – F) for zebrafish embryos 48 hpf 
after exposure to different chemicals (methods: 2. 3, 3.1.1, 3.1.2, 3.1.3 and 3.1.4).  
(A) Morphological, (B) vaso-, (C) neuro-, (D) myotoxic effects and (E + F) apoptotic effects of ethanol, 
SU4312, triclosan, genistein and cartap ((A) mean ± SEM of 3 independent experiments with 21 – 50 embryos 
each, (B) 8 ISVs of 3 – 6 embryos each, (C) 5 – 6 embryos each, (D) 3 – 5 angles of hemi-segments of 3 – 6 
embryos each and (E + F) 3 – 4 embryos per treatment; *p<0.05, **p<0.01, ***p<0.001; one-way ANOVA with 
post-hoc Dunnett’s multiple comparison test). Frames indicate the first significant effect of the corresponding 
endpoint (red: MBFA, green: fluorescence assessment). 
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3. 4 Linkage between transgene phenotype and gene expression  
To investigate the correlation between the endothelial marker gene expression and ISV 
developmental impairments, the expression of fli1a was analyzed by quantitiative RT-PCR. 
Additionally, the endothelial marker genes cdh5 and flt4 were measured to investigate their 
value as early markers of vascular defects. To find a linkage between the effect phenotype of 
the Tg(gfap:GFP) embryos and the corresponding molecular initiating event, the expression 
rate of the neuromarker gfap was assessed as well.  
For each substance, two concentrations were tested, one resulting in no morphological effects 
and a second causing significant morphological effects compared to the control. However, the 
results of the PCRs showed no statistically significant changes in mRNA-expression ratios of 
both, the endothelial and neuronal marker genes (Fig. 26). However, even though statistically 
non-significant, fli1a expression hinted towards a slight concentration dependency for e.g., in 
triclosan, genistein and cartap treatment (Fig. 26 A, C, E) and gfap expression for ethanol, 
SU4312 and cartap treatment (Fig. 26 A, B, E). 
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Fig. 26: mRNA-expression ratios of specific cell marker genes in substance-treated zebrafish embryos of 
48 hpf, compared to the mRNA-expression ratio in control embryos (method: 2. 8).  
Bar chart depicting the mRNA-expression ratios of fli1a, cdh, flt4 and gfap in embryos exposed to (A) 0.61 µM 
and 1.44 µM of SU4312, to (B) 1.93 µM and 2.45 µM of triclosan, to (C) 4.40 µM and 10.47 µM of genistein 
and to (D) 0.42 µM and 0.84 µM of cartap compared to untreated control embryos, respectively. No significant 
changes in expression ratios were found (the Students t-test was performed). All mRNAs were quantified by real 
time RT-QPCR and normalized to rpl8 and s18 rRNA expression according to the 2∆∆Ct method of Pfaffl, 2004 
(mean ± SEM of 3 independent experiments). 
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4. Discussion 
In the present thesis, I investigated the potentials of fluorescence microscopy to enhance the 
zFET. The zFET finds application in environmental and chemical hazard assessments as an 
alternative test system for the assessment of acute toxicity. The conventional test only 
accounts for lethal morphological endpoints while disregarding any sublethal effects, which 
may provide additional information on the toxicity. Consequently, limiting the zFET to acute 
toxicity diminishes the informative value as well as the specificity of the test. Hence, I 
developed an approach, which considers all sublethal morphological effects occurring in the 
embryos, and, in parallel, uses cell-specific fluorescent labels to gain supplementary 
information on the toxicity. The Tg(fli1:EGFP)y1 transgenic embryos can reveal defects of 
blood vessel development and the Tg(gfap:GFP) embryos detect effects on glial cell 
development, fluorescent stainings with an anti myosin antibody allow conclusions on the 
myotoxic potential of substances. Lastly, acridine orange in vivo staining shows substance-
induced changes in the apoptosis rate. The vascular system, the neural tube and the myotom 
of the zebrafish embryo are well-defined organs/tissues, which enable the detection of 
chemical-induced changes in morphology by fluorescence microscopy. For a proof-of-
principle, three chemicals with different mode of actions and relevant occurrence in the 
aquatic environment, namely triclosan (Singer et al., 2002; Ruedel et al., 2013), genistein 
(Rearick et al., 2013) and cartap (Berg, 2001), were assessed. By combining different the 
phenotypic effect assessments, I achieved an increase in test sensitivity, widened the 
applicability and enhanced the explanatory power of the zFET. 
 
4. 1 Shortcomings of the MBFA 
The determination of sublethal effects in the zFET by eye is prone to errors and requires some 
experience. The MBFA of malformations during a conventional zFET is usually carried out 
by a single examiner who evaluates the presence or absence of defined lethal and sublethal 
morphological endpoints in every single embryo. The outcome of the evaluation varies with 
the experience of the examiner and thus, reflects on the concentration-effect curves generated 
from the data. For instance, reduced blood circulation is a common sublethal effect. It is a 
good example for an endpoint difficult to assess for an untrained examiner. This sublethal 
effect can only be evaluated after 48 hpf and is therefore not a very sensitive parameter of the 
zFET. However, vasotoxic effects can in general be detected earlier since vasculogenesis in 
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zebrafish embryos drives the formation of the two main axial vessels, the dorsal aorta (DA) 
and more ventrally, the posterior cardinal vein (PCV) already within the first 24 hpf 
(reviewed in Baldessari and Mione, 2008). Also the blood flow starts at this time point, but is 
unambiguously observable in the DA and PCV not before 48 hpf (Kimmel et al., 1995). 
Overall, the blood circulation in the small vessels between the somites, the ISVs, is difficult 
to assess by bright field microscopy. The advantage of using fluorescent fish is that it allows 
illumination of cells or organs thereby embryonic structures, which would otherwise not be 
visible in bright field microscopy. This is for instance reflected in the SU4312 treatment, 
where the effect disturbed blood circulation was not observable untill a concentration of 2.23 
µM. In contrast to the fluorescence assessment, where already 0.61 µM of SU4312 showed 
significant truncations of the ISVs (Fig. 16 B). In this thesis, the illumination and 
visualization of the ISVs in the trunk of fluorescent embryos were exploited in favor of an 
earlier and specific vascular effect detection and facilitation of effect interpretations. Another 
example of an earlier and sensitive detection of effects by fluorescence microscopy was 
provided by the cartap exposure. Here, the sublethal endpoint malformation of notochord was 
recorded significant in the MBFA only at higher concentration than for the fluorescent 
endpoint ISV-length (Fig. 25). Additionally, the visualization of the neural tube in the 
Tg(gfap:GFP) line allowed a detection of the cartap-induced aberrant morphology of the 
neural tube (Fig. 18 E), an effect which could not be detected by the MBFA at all.  
Effects, which are easily and unmistakably detectable by MBFA are usually well distinct in 
the embryo. Thus, it is easily possible to over-look subtle effects on the morphological level. 
And besides the need of an experienced and trained examiner, the standard zFET MBFA 
suffers from low objectivity. This is reflected by high standard deviations and a low 
reproducibility. Hence, the main challenges when using the zFET are inter-laboratory 
reproducibility as well as regulatory constraints in terms of data acceptance. Furthermore, the 
standard MBFA allows no graded evaluation of the impact. Only presence or absence of the 
individual effects (quality assessment) are recorded and evaluated, resulting in a loss of 
information. Consequently, additional endpoints are needed which are less objective and 
which can be quantified.  
 
4. 2 Specific toxicity detection  
The EGFP-based examination of the ISV development provided a qualitative as well as 
quantitative additional endpoint for the zFET, which increases the test sensitivity for 
substances affecting the vascular development. The qualitative ISV defects in the 
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Tg(fli1:EGFP)y1 embryos (ISVFA) indicated a vasotoxic potential of substances with higher 
resolution and at lower exposure concentrations than the assessment by bright field 
microscopy. The effect thresholds of the ISVFA of the vasotoxic compounds tested were all 
below the MBFA (Fig. 14). However, the concentration-effect curves based on general 
morphology (MBFA) showed steeper slopes than the ISVFA curves i.e., a minimal increase 
in substance concentration caused huge differences in the effect level. This generally suggests 
a high toxic potency of a chemical. Here, the steepness of the slopes was caused also by the 
multiparametric effect assessment where the effect level is based on the sum of many 
different (morphological) effects. Contrary, the ISV assessment is a monoparametric 
assessment, causing the gradually increasing blood vessel development curves of cartap, 
genistein and triclosan. 
The EGFP signal in Tg(fli1:EGFP)y1 embryos is suitable for a precise and sensitive detection 
of abnormal vasculature or blood circulation. Nevertheless, despite a higher sensitivity of the 
fluorescence, the ISVFA endpoint still suffers from the shortcomings of other morphological 
endpoints in bright field microscopy, like low objectivity, high error rate and sophisticated 
assessment, when used as a qualitative measure. I was able to improve the assessment within 
the Tg(fli1:EGFP)y1 embryos by including the measurement of the ISV-length. This parameter 
can be assessed and quantified even by untrained test evaluators. The quantification of the 
ISV growth in Tg(fli1:EGFP)y1 provides a robust and quantifiable vascular development 
endpoint after 24 and 48 h of substance exposure.  
Furthermore, I was able to show that the ISV-length can also be used as a quantifiable 
measure of the developmental stage of the embryo and may therefore serve as an objective 
measure of pollutant-induced developmental delay. The identification of developmental 
stages in zebrafish embryos is otherwise estimated based on published staging series (Kimmel 
et al., 1995).  
 
Besides the vasotoxicity assessment, I evaluated neurotoxic effects on the neural tube 
fluorescence of Tg(gfap:GFP) embryos. The gfap-expressing cells are mainly located in 
RGCs and astrocytes of the central nervous system (Bernardos and Raymond, 2006). The 
region of the neural tube was selected for measuring the fluorescence intensity as the gfap-
coupled GFP-expression is strongest along the spinal chord of 24 and 48 hpf embryos 
(Bernardos and Raymond, 2006). The fluorescence intensity of the neural tube of 24 hpf 
embryos was deemed indeterminable due to the spontaneous movements at this time point. 
The GFP-signal of this transgenic line is not as strong as the EGFP-signal of Tg(fli1:EGFP)y1 
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embryos and required longer exposure times (~ 1.3 sec) during z-stack image acquisition. 
Thus, the time required was too long to suppress the spontaneous movement of living 24 hpf 
embryos without risking the overdose of anesthesia. Therefore, a 24 h assessment endpoint 
proved not suitable for live embryos and an alternative method using fixed embryos was 
considered. However, the measurement of the fluorescence intensity of live 48 hpf 
Tg(gfap:GFP) embryos was suitable to measure a negative impact (weaker fluorescent signal) 
on the neural development by ethanol, triclosan and genistein exposure (Fig. 18 A+D and Fig. 
19 A+D).  
However, I was not able to confirm the fluorescence intensity of the Tg(gfap:GFP) embryos 
as a direct indicator of neurotoxicity, as no correlation of the intensity decrease with 
functional effects (e.g., no spontaneous movement at 24 hpf) could be found. Maybe with the 
help of behavioral assays a neurotoxicity correlation could be determined for Tg(gfap:GFP). 
Although further research is still required, my data suggest that the fluorescence intensity of 
gfap-expressing cells is not an indicator of general neurotoxicity, but rather of a specific 
impact on neural development and thus, of neural development toxicity.  
  
The whole-mount antibody staining method was an easy and fast method to visualize and 
locate specific tissues or cells in fixed organisms. In 24 hpf embryos the muscle morphology 
was not yet fully formed to give sharp contrasts of the single muscle fibers. This obscured the 
outline and thus, the visualization of the angle between the hemi-segments. Therefore, the 
myotoxic potential of the chemicals tested could be determined only after 48 h of exposure. 
With this fluorescence endpoint, I confirmed concentration-dependent aberrations in muscle 
fiber morphology of ethanol, genistein and cartap treated embryos (Fig. 20 A, D, E and Fig. 
21 A, D, E). Aberrant muscle morphology affects the locomotion and impacts on survival of 
the fish due to hatching, foraging or escape difficulties. Moreover, the quantification of the 
angle between the two hemi-segments can specify the degree of teratogenicity, as aberrant 
muscle morphology displays embryo malformation (Sylvain et al., 2010). Effects, which 
indicated altered muscle morphology in the MBFA were malformations of the tail and an 
undulating notochord (Fig. 12 A, D, E), but these endpoints are not measurable. Hence, the 
immunostaining method provided a quantifiable endpoint what enabled the evaluation of the 
degree of teratogenicity. 
 
Apoptosis is a highly conserved driving force of embryogenesis (Abrams et al., 1993). 
Developing tissues or organs produce excess cells, which are removed by apoptosis as an 
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important step in normal development. Environmental or substance-induced influences can 
impact apoptosis (Parng et al., 2002), what makes apoptosis an interesting endpoint in 
ecotoxicology. AO stains the nuclei of cells by interaction with the chromatin (Abrams et al., 
1993). It has the advantage of a rapid analysis of apoptosis in live embryos, but it does not 
allow discrimination between apoptotic and necrotic cells. A combination of AO with 
ethidium bromide would have facilitated this differentiation, but was not conducted, as the 
assessment was aimed to be performed on living embryos. Hence, the results of the non-
invasive AO staining method showed dead cells independently of induced necrosis or 
apoptosis. Since it was not possible to achieve this specific conclusion, the fluorescent cells 
were summarized as apoptotic cells.  
Cole (2001) has described the normal patterns of apoptosis in various structures of the 
developing zebrafish embryos. The dynamics of apoptosis in zebrafish embryos follow a time 
course and mainly occur during neurulation and somitogenesis (Cole, 2001). By 20 hpf, 
apoptotic events are mostly completed and reduced to a basic level in the embryo (Cole, 
2001). This is why I only determined the apoptosis rate of 48 hpf embryos. Cole (2001) 
discovered a small amount of apoptotic cells in the Rohon-Beard neurons, musculature, 
urogenital system and median fin fold in the trunk region of normally developed embryos 48 
hpf. Based on the image analysis, I observed additional apoptotic cells, which were 
unspecifically scattered across the trunk, but also an increase in apoptotic cells mainly in the 
region of the neural tube, depending on the chemical tested (Fig. 22). Genistein exhibited the 
strongest impact, showing a dense area of apoptotic cells in the ROI (Fig. 22 A, C, D and Fig. 
23 A). Consequently, the fluorescent cell counting of this apoptotic phenotype showed the 
need of a different sensitive assessment method since e.g., overlapping single cells were 
miscounted as one big cell, which caused an underestimation of the number of apoptotic cells. 
The application of an alternative quantification method became necessary and therefore the 
overall fluorescence was measured across the ROI instead (Fig. 23 A+B). For unspecifically 
induced apoptosis with apoptotic cells spread over a certain region, as in the case of ethanol 
and triclosan, counting of single fluorescent cells was more suitable and thus more sensitive, 
whereas area dense apoptosis was assessed with higher sensitivity by measuring the total 
fluorescence intensity (Fig. 23 and Fig. 24). Maybe a combination of both assessments would 
be the best method for the most significant and realistic analysis of chemically induced 
apoptosis. For realizing such a combined method, more data of more substances with a high 
and area specific increase of apoptotic cells, like genistein, should to be tested.  
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It should be noted that an automation of the assessment of apoptosis either based on cell 
counting or measuring total fluorescence intensity, would not provide information on 
apoptosis tissue specificity otherwise obtainable by the manual image-analysis. With regard 
to an automated image-analysis, it would be useful to integrate a tool for an automated 
localization of fluorescent cells. 
 
4. 3 Mechanism of toxicity 
In hazard and risk assessments applied acute or chronic fish test data deliver little information 
about the mechanism of action of chemicals. However, such information is a prerequisite in 
order to reliably predict the potential toxicological impact on the environment as well as 
humans. In this study, anomalies of main embryonic structures were specifically detected and 
quantified with the help of fluorescence microscopy. To investigate if they enable a 
mechanistically specific toxicity assessment within the zFET, model compounds with 
different toxicity pathways had to be tested. Other studies already highlighted the multiplicity 
of possible actions of triclosan (Oliveira et al., 2009), genistein (Sassi-Messai et al., 2009) and 
cartap (Zhou et al., 2009), claiming they have more than one mode of toxic action. Hence, 
their effects were studied to investigate whether their differing modes of action impact 
differently on the newly established fluorescence endpoints and whether the results inform on 
the toxicity pathways. 
 
For triclosan, effects on the ISV-length occurred before any other exposure effects. However, 
the lack of a concentration-dependency of the ISV-length together with the observed 
phenotype of a 10-somite staged embryo in the MBFA at 24 hpf (Appendix 8. 1, Table 8), led 
to the assumption that triclosan caused growth retardation rather than a specific vasculo- or 
angiogenic developmental delay. Even though the embryos appeared smaller than the control 
embryos, the mean angle between hemi-segements of the embryo was no indicator for growth 
retardation. In contrast, the vital AO staining showed triclosan-induced effects on the 
apoptosis rate in the 48 hpf embryos (Fig. 23 C). Triclosan caused an increase in apoptosis 
what could indicate growth retardation, as the amount of apoptotic cells should be reduced 
with progressed normal embryonic development (Cole, 2001). General growth retardation 
would also explain that the effect on ISV-length diminished at 48 hpf, where a significant 
reduction in ISV-length was only observed at triclosan concentrations of ≥ 2.45 µM (Fig. 16 
B). A developmental delay in triclosan-treated embryos was described previously by a study 
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of Oliviera et al. (2009). I could confirm the typical effect phenotype of triclosan by the 
additional fluorescence endpoints. 
Genistein induced impairment of the ISV outgrowth leading to thinner appearances and, with 
increasing concentrations, to stronger truncations and malformations (Fig. 15 C and Fig. 16 
C). Kalin et al. (2009) identified a similar vessel phenotype in Xenopus larvae after genistein 
exposure. Genistein exhibits anti-angiogenic activity, mediated by a down regulation of 
VEGF gene expression due to inhibition of the activation of hypoxia-inducible factor-1 (HIF-
1) (Büchler et al., 2004). HIF-1 mediates transcriptional activation of vessel dilation, 
angiogenesis and erythrogenesis via up-regulation of e-NOS, VEGF and erythropoietin (EPO) 
(Jensen, 2007). Genistein affected the ISV development differently to SU4312 since the 
embryos of both treatments displayed different ISV phenotypes. According to other described 
mechanism of action of genistein related to vasculo- and angiogenesis (Sassi-Messai et al., 
2009; Schiller et al., 2013), inhibition of the VEGFR pathway is in fact only one of several 
possible mechanisms. SU4312 instead was specifically developed as a VEGFR antagonist for 
cancer treatment (Molina et al., 2007). I could further demonstrate that genistein induced 
apoptosis in a dose-dependent manner by vital AO staining (Fig. 24 D). Interestingly, no 
apoptotic cells were detected outside the CNS, an effect of genistein already described by 
Sassi-Messai et al. (2009). As suggested by Kanungo et al. (2008), genistein-induced 
apoptosis was likely not attributed to Rohon-Beard neurons as they are located in the dorsal 
part of the spinal cord (Kimmel et al., 1995) and normally occur only occassionally. Hence, 
the high number of apoptotic cells induced by genistein probably originated from cells 
abundantly present in the developing CNS, like the RGCs. Strengthening this assumption, 
genistein-treated Tg(gfap:GFP) embryos lost fluorescence intensity within the neural tube, 
which demonstrated the impact of genistein on gfap-expressing cells. The additionally 
observed increase of fluorescent cells in the neural tube by AO staining confirmed that 
genistein induced apoptosis of RGCs or/and astrocytes. Transcriptome analysis performed by 
Schiller et al. (2013), showed that genistein disrupts brain and nervous system development 
pathways of zebrafish embryos already at low concentration (EC20-concentration). Specific 
up-regulation of the gene cyp19a1b was found in genistein-treated embryos (Schiller et al., 
2013). Cyp19a1b encodes a brain predominant isoform of aromatase (Fenske and Segner, 
2004). It is expressed restrictively in RGCs and is strongly stimulated by estrogens (Le Page 
et al., 2005; Pelligrini et al., 2007; Xing et al., 2014). Kishida et al. (2001) suggested that 
cyp19a1b is necessary for CNS development and thus represents a reliable marker for testing 
neurotoxic effects of EDCs during embryogenesis. A linkage between the expression of 
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cyp19a1b and gfap seemed likely, but was not investigated. Brion et al. (2012) showed with 
the transgenic Tg(cyp19a1b-GFP) line that RGCs can be a direct target of many EDCs, 
thereby emphasizing the need for research on potential effects of EDCs on brain development. 
In this context, the embryos of the Tg(gfap:GFP) may be an additional tool for screening 
EDCs affecting neurogenesis.  
In addition, Schiller et al. (2013) found a down regulation of genes responsible for the 
formation of the myelin proteolipid protein, which is the major component of myelin. This 
indicates that genistein not only affects GFAP-positive RGCs and astrocytes as shown in this 
study, but also other glial cells in the CNS like, e.g., the GFAP-negative oligodendrocytes, 
which are responsible for the myelination (Xing et al., 2014) (Fig. 5). Hence, the results of 
our lab on genistein provide some evidence that genistein impacts the development of the 
CNS. It would be interesting to see, if a later genistein exposure of Tg(gfap:GFP) embryos 
had no effects on the GFP-signal. This would indirectly confirm that the effect of genistein is 
most likely limited to the neurogenic phase of zebrafish embryos.  
 
Cartap was the only substance without MBFA-detectable impairments of the blood 
circulatory system or malformations of the heart. Instead, concentration-dependent notochord 
deformations were observed (Fig. 12 E). Cartap is described as a neurotoxin, which can cause 
notochord deformation by inhibition of lysyl oxidase enzyme activity (Zhou et al., 2009). The 
inhibition of the lysyl oxidase destabilizes the cross-linkage of collagens and elastins of the 
notochord and results in a well-described undulating notochord phenotype, which cause 
malformations of the chevron-shaped somites (Anderson et al., 2007; Gansner et al., 2007; 
van Boxtel et al., 2010). I could confirm the disturbed chevron-shaped somites by the 
immunostaining of the muscle fibers (Fig. 21 E). These malformations were most likely the 
reason for the disorganized arrangement of the ISVs caused by cartap (Fig. 15 D). Both 
defects occurred concurrently with the ISV-length decrease and the increase in ISV spacing 
irregularities and in concordance with the progression of the notochord deformations. This 
suggested that the effects on ISV pattern formation were due to the irregular notochord 
development rather than a primary vasotoxic effect. The fluorescent endpoint ISV 
development therefore indirectly displayed the primary notochord effects of cartap at below 
EC50 concentrations. Interestingly, effects on the ISV development occurred at lower 
concentrations than effects on muscle morphology (Fig. 25 B+D). Thus, cartap was probably 
not primarily myotoxic as well. Furthermore, the impacted morphology of the neural tube was 
most likely a consequence of the wavy notochord, as it had quite similar deformations (Fig. 
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18 E). However, an effect of cartap on the fluorescence intensity in the neural tube of 
Tg(gfap:GFP) embryos was not detectable (Fig. 19 E). Hence, the GFAP-positive astrocytes 
or RGCs were unaffected by cartap treatment. The neurotoxic potential of cartap is 
presumably due to influences on the development of motorneurons (Muth-Köhne et al., 
2012). Consequently, fluorescence intensity of gfap-expressing cells does not seem to be an 
indicator for general neurotoxicity, but rather for a specific impact on neural development, as 
already postulated.  
 
4. 4 Fluorescence endpoints influence test sensitivity 
Fluorescence-based approaches have already demonstrated to be sensitive and reliable 
methods for the analysis of adverse effects in zebrafish embryos upon substance exposure 
(Dai et al., 2013). The studies of Zhang and Gong (2013) and Muth-Köhne et al. (2012), for 
instance, have shown that fluorescence-based methods proved to be more sensitive for the 
detection of embryo toxicity than the non-fluorescent morphological effect assessment. Zhang 
and Gong (2013) used a transgenic zebrafish line to measure the axon length in living 
embryos in order to identify neurotoxins. Their fluorescence endpoint ‘axon length’ was 
about 10-times more sensitive than the most sensitive morphological bright field endpoint 
’heartbeat’ (Zhang and Gong, 2013). Additionally, Muth-Köhne et al. (2012) demonstrated a 
sensitive detection of neurotoxins by fluorescence whole-mount immunostainings of 
motorneurons in zebrafish embryos.  
Low substance concentrations may exert subtle and barely detectable effects on the 
morphological level, which could be missed in a test solely based on MBFA like in the case 
of the conventional zFET, as shown in Fig. 25. In this study, the fluorescence endpoints 
showed a higher sensitivity for a chemicals’ primary toxic potential (vaso-, neuro-, myotoxic 
or apoptotic potential). Effects were determined earlier and/or at lower concentrations in the 
fluorescent test approach: I was able to show that embryos of Tg(fli1:EGFP)y1 allow an 
increase in test sensitivity for vasotoxic substances and the counting method of fluorescent 
cell/ROI in AO stained wild type zebrafish embryos showed also a sensitivity increase for 
detecting effects (Fig. 25 A, E, F). When significant effects occurred in the zebrafish 
embryos, then the fluorescence endpoints fluorescence intensity of Tg(gfap:GFP) and the 
angle between hemi-segments neither caused an increase nor a decrease in the test sensitivity 
for triclosan, genistein and cartap compared to the MBFA (Fig. 25 A, C, D). These two 
fluorescence endpoints did not enhance the identification of toxic actions of the standard 
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zFET for the tested model chemicals. I therefore concluded that none of the tested model 
chemicals were primarily myotoxic or neurotoxic. 
In contrast to the ISV-length, which appeared to be a more sensitive indicator for vasotoxicity 
than examining morphological defects. This was demonstrated by decreased ISV-lengths 
occurring at lower exposure concentration than the morphological effects reduced or missed 
blood circulation or even the cumulative morphological effect threshold (Fig. 25 A+B). Also 
the direct comparison of the quantitative assessment methods, ISVA and MBFA underlined 
this assumption: For the positive control, the small molecule SU4312, the effect maximum at 
the highest test concentrations and also the steepness of the curves were similar for both 
ISVFA and MBFA (Fig. 14 A). At lower concentrations, the ISVFA was more sensitive 
confirming the primary vasotoxic potency of SU4312. Triclosan showed a higher sensitivity 
at the vasotoxic than the teratogenic level, as demonstrated by the lower EC50 value and 
effect thresholds (Fig. 14 B). In the case of genistein and cartap, it was difficult to decide on a 
more sensitive toxicity endpoint based on the effect curves. Due to the gradual effect increase 
in the ISVFA, very similar EC50s but higher EC80 values and lower EC10 values were 
derived than in the MBFA for genistein and cartap (Fig. 14 C+D). This means that the ISVFA 
allowed a more sensitive effect detection at lower concentrations than the MBFA and 
distinguished vasotoxic from non-vasotoxic substances below the 50% effect level. At low 
concentrations, the specific ISV effects were presumably not yet superimposed by systemic 
toxicity effects, which occurred increasingly upon treatment with increasing concentrations of 
genistein and cartap. Accordingly, the negative control pentoxifylline was classified as 
primarily non vasotoxic (Fig. 17 C) contrary to the positive control SU4312, which acts 
primarily vasotoxic (Molina et al., 2007; Tran et al., 2007). Due to the similarity of the 
ISVFA EC-curve to SU4312, triclosan was classified as a vasotoxicant, whereas genistein and 
cartap appeared primarily non vasotoxic (Fig. 14 C+D). 
However, the most sensitive effect assessment for all tested chemicals was the ISV-length 
measurement (Fig. 25). Even for cartap the ISV-length was more sensitive than the MBFA of 
the standard zFET and the muscle morphology assessment (angle between hemi-segments). 
Surprisingly, no primary vasotoxic potential of cartap is described in literature (Sylvain et al., 
2010). This implied that weak to severe ISV defects occur earlier or, like in the case of cartap, 
are more clearly to detect in embryos than weak notochord malformations (Fig. 16 and Fig. 
13). The ISV-length may also be an early toxicity endpoint as their development starts very 
early in the embryogenesis and thus can be impacted by early chemical exposure.  
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Nevertheless, a prerequisite for endpoints assessing specific toxicity are appropriate control 
substances. The positive controls, ethanol and SU4312 were selected to achieve the most 
sensitive assessment based on at least one of the fluorescence endpoints. Upon the ethanol 
treatment all fluorescence endpoints responded earlier than the MBFA endpoints. Therefore, 
the neuro- and myotoxic potential of ethanol was confirmed, as well as the validity of the 
corresponding fluorescence endpoints. I could also show the impact of ethanol on the vascular 
development and apoptosis (Fig. 25). However, the apoptosis rate was not affected by ethanol 
in a clear concentration-dependent manner. Statistically, effects of ethanol were observed; 
hence, ethanol could be used as positive control for chemical-induced apoptosis, but as an 
unspecific one. For a more specific and thus sensitive control e.g., neomycin should have 
been selected. Neomycin is an antibiotic, which is known to induce apoptosis concentration 
dependently (Parng et al., 2002). 
In contrast to ethanol, SU4312 only induced concentration-dependent effects on the vascular 
system. This was determined with higher sensitivity by ISV-length measurements than by 
conventional zFET assessment methods. Due to its high specificity, as a VEGF antagonist 
(Molina et al., 2007), SU4312 was a suitable negative control for all other fluorescence 
endpoints. Pentoxifylline served as negative control for the assessment of a substance’s 
impact on blood vessel development. As described before (chapter 3.1.1), pentoxifylline 
caused no significant effects on the ISV-length, except for the highest test concentration of 
1019.44 µM (Fig. 17 D). As pentoxifylline exhibited moderate fish embryo toxicity in the 
MBFA, it was obviously not the best selection for a negative control in the fluorescence 
assessment. Besides, pentoxifylline-induced effects on the blood flow may have influenced 
the vessel outgrowth, as suggested by Yashiro et al. (2007). They showed that 
haemodynamics govern the VEGFR signaling and the aortic arch morphogenesis in mice 
(Yashiro et al., 2007). Disturbed blood flow was detected at low concentrations of genistein 
and triclosan (Fig. 12 D+C) along with effects on the relative ISV-lenght of the 48 hpf 
zebrafish embryos. It may therefore be speculated whether the positive hemorheological 
property of pentoxifylline would partially explain the absence of ISV defects in all but the 
highest exposure concentration (Fig. 17 D). My data could not unequivocally confirm that the 
ISV endpoint is not influenced by general toxicity. To substantiate this assumption further, 
other negative control substances have be tested in the future. Nevertheless, the selected 
control substances proved useful in confirming general test validity of the fluorescence 
endpoints and the specificity of the particular parameters. A thorough validation, however, 
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will require more control (negative and positive) and test chemical exposures in more than 
one laboratory.  
 
4. 5 Phenotype versus gene expression 
Molecular level parameters measured in ecotoxicological tests are characterised by a high 
sensitivity, specificity and speed but of low ecological relevance at the organism and 
population level. Gene expression analysis using PCR can measure the chemical-induced 
impact on a gene with high sensitivity in relatively little time. It was therefore hypothesised 
that measuring genes with PCR would reveal embryo toxicity earlier and quicker compared to 
the bright field and fluorescence endpoints. 
In order to test this, early marker genes of angio- and vasculogenesis in zebrafish, fli1a, cdh5 
and flt4 (Thompson et al., 1998; Covassin et al., 2006; Baldessari and Mione, 2008) and the 
neuromarker gfap were analyzed by quantitative RT-PCR. The aim was to compare the results 
of gene expression with the results of the ISV-length and gfap-transgenic assessment in terms 
of earlier detection and higher sensitivity. Yet, I could detect no substance-induced alterations 
in mRNA expression of the selected genes (Fig. 26). Since fli1 and cdh5 are not only 
expressed in the ISVs, but also in most other blood vessels (Thompson et al., 1998; Brown et 
al., 2000; Larson et al., 2004), it is possible that the downregulation related to the absence or 
truncation of ISVs in the trunk region was too minimal to be detected by RT-QPCR. The 
impact on blood vessels in the head region was not conspicuous and presumably neglectable 
and therefore not measurable in the RT-PCR despite amplification. Regarding the receptor 
tyrosine kinase flt4, presumably the wrong time point for the RT-PCR analysis was chosen 
since the expression evidently starts at 18 hpf and vanishes with further development and is 
no longer observable at 48 hpf (Thompson et al., 1998).  
Evidently, the studied genes were deemed unsuitable as marker genes. To detect effects 
before they translate into a morphological phenotype more suitable genes will have to be 
chosen. Moreover, it should be considered that usually the course of molecular events is 
organized as cascades of aligned pathways defining the mechanism of action. Therefore, 
single genes are not always suited for early toxicity detection (Schiller et al., 2013). 
Nevertheless, these results highlight that quantitative RT-PCR approaches are not necessarily 
the most sensitive measure of exposure effects, in particular when they have already been 
translated into morphology and vice-versa. Instead, a fluorescence-based phenotypic 
assessment method using transgenic zebrafish lines like Tg(fli1:EGFP)y1 or Tg(gfap:GFP), can 
directly link effects on gene expression with cellular and morphological impairments.  
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While techniques like quantitative RT-PCR or in situ hybridization are used for hypothesis-
driven monitoring of expression changes of selected candidate genes, transcriptome analysis, 
like microarrays allow screening of large gene sets or entire transcriptomes for differentially 
expressed genes. However, neither RT-PCR nor transcriptome analysis provide information 
on effect localization. In addition, these methods are not able to detect effects in living 
organisms and deliver no information on time-related effects. Consequently, there is a need 
for methods providing mechanistic understanding and spatio-temporal resolution of effects.  
In this study, fluorescent phenotypic endpoints have demonstrated to deliver a link between 
transcriptome effects and morphological impairments. For genistein for example, my results 
could show that apoptosis is in fact induced and that the nervous system development is 
impaired, while both effects were predicted by Schiller et al. (2012) based on transcriptome 
analysis data. Furthermore, the fluorescence endpoints enabled a localization of chemical-
induced effects on the neural tube, more precisely on the RGCs and/or astrocytes. These 
fluorescence endpoints linked the disturbed neural development and increased cell death to 
the molecular initiating events. Only a robust correlation between molecular biomarkers and 
phenotypic endpoints can strengthen the acceptance and application of e.g., gene expression 
profile data in risk assessment (Calzolai et al., 2007; Ankley et al., 2010; Volz et al., 2011). 
And AOPs are intended to be used by regulatory agencies, which show their commitment by 
their active engagement in the AOP program activities of the OECD. Fluorescent phenotypic 
endpoint methods will play an important role in the recognition of key events and the 
development of key event assays within the new AOP (Adverse Outcome Pathway) driven 
paradigm in environmental risk assessment. 
 
4. 6 Application aspects and cost-benefit considerations  
The combination of fluorescent and non-fluorescent, lethal and sublethal endpoints allowed 
an integrated effect assessment, which provided the ability to characterize chemicals by 
toxicity classes (e.g. neurotoxic, vasotoxic or teratogenic). The ultimate goal would be to 
apply fluorescence endpoint methods in screening applications. In a tiered toxicity testing 
approach, screening methods and endpoints are necessary to prioritize chemicals for further 
higher-tier testing. A resourceful screening battery with meaningful mechanistic and robust, 
reliable read-outs could contribute to the reduction of unnecessary follow-on tests on animals. 
An in vivo screening assay should fullfill the criteria of biological relevance, fast execution, 
standardization and acceptable personnel and financial expenditures. The zebrafish embryo 
provides a small transparent organism with a fast development and which can be obtained in 
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large quantities making it particularly well suited for a whole organism screening approach. A 
limitation of in vivo screening models with invertebrates (e.g., Caenorhabditis elegans), 
which are used in drug discovery (Segalat, 2007), is the fact that they lack many organs, 
which are important to vertebrate biology and physiology. Zebrafish instead possess most 
organs and functions also present in higher vertebrates, such as the cardiovascular system 
with a multi-chamber heart and circulation within arteries and veins, immune system and 
kidneys. Zebrafish embryos have most organs formed only within 48 hpf (Kimmel et al., 
1995), which is hard to match by other vertebrates. Concurrently, they fit into microwell 
plates and can directly be exposed by immersion requiring low amounts of test compounds 
(Lieschke and Currie, 2007). These advantages have already been exploited by many 
investigators who have performed drug screening assays with the zebrafish embryo 
(Mattingly et al., 2001; Blechinger et al., 2002; Hill, 2003; Behra, 2004; Yu, 2005; Hernández 
and Allende, 2008; Chen et al., 2009). However, the majority of these studies had the 
shortcomings of a time-consuming assessment lacking automation of analysis. An automated 
and thus fast image analysis for the zFET is a fundamental requirement for potential HTS 
applications (the automation of the front-end workflow is another), which should be attractive 
for commercial use. 
In this project, sublethal endpoints of specific toxicity were defined on the basis of 
fluorescence-labeled cells, tissues and anatomical structures, which were quantifiable and 
responsive to exposure. Besides, the application of fluorescence microscopy opened up many 
possibilities of computer-based image analysis to simplify and accelerate the test assessment 
and increase objectivity. The advantage of using fluorescence image analysis is the lower data 
volume of binary images compared to bright field images (Liu et al., 2012). The smaller 
amount of information stored for each pixel simplifies data processing and also the 
development of algorithms for automated computer-based image analysis.  
The analysis of the fluorescence intensity of the Tg(gfap:GFP) embryos and of the AO 
staining were the most promising endpoints for an automated quantification. Parng et al. 
(2002) introduced a simple method to analyze fluorescence intensity of zebrafish embryos by 
using a fluorescence plate reader. However, I tried to analyze the fluorescence intensity of the 
Tg(gfap:GFP) and of the AO-stained embryos according to Parng et al. (2001), but neither a 
concentration dependency nor a statistically relevant difference could be determined. 
Interestingly, Parng et al. (2002) only showed for one substance (neomycin) the 
concentration-dependent results of the automated quantification. Furthermore, they could not 
determine any statistical differences to the control group (Parng et al., 2002). This led to the 
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assumption that the fluorescence plate reader might be a rather imprecise method and was 
therefore considered not appropriate for my purposes. Parng et al. (2002) provided only a 
basic screening method of AO-stained zebrafish embryos in a 96-well microplate 
fluorescence reader.  
Besides automated image analysis, orientation and dechorination of the embryos is another 
challenging parameter in HTS applications (Liu et al., 2012). If the position of the embryo is 
not right, defects or malformations are not detectable. In this project, one initial idea to deal 
with the problem of an unfavorable position of the embryo was to process z-stack images into 
3 D-projections, which would then enable a virtual rotation. A confocal microscopic system 
like the HTS OPERA System of Perkin-Elmer can provide high-resolution images for 3D-
projection. However, previous application attempts with the in-house OPERA system had 
revealed problems concerning the available microscopic objectives and the illumination of the 
test vessels. Additionally, U-bottom well plates did not fit in the OPERA system, what would 
have complicated the right positioning of the embryo and hence, the assessment. For this 
project, it was decided that the resolution of these issues was too cost-intensive and the idea 
of using the OPERA system dismissed. Moreover, the assessment of the newly defined and 
developed fluorescence endpoints revealed an easily handled image acquisition, as the 
selected endpoints were all within the trunk/tail of the embryo, which is the most lateral 
region of the zebrafish embryo. Taking z-stacks of these regions ensured precise and good-
definition images of the morphological details without the need of 3D-projection.  
Nonetheless, the preparation of the embryos for image analysis was very time-intensive, not 
least due to the manual dechorionation of embryos as well as due to the mounting procedure. 
The manual positioning makes the test design unfeasible for HTS. Letamendia et al. (2012) 
were able to develop a HTS platform, where manual manipulation of zebrafish embryos is not 
necessary, but only for a rough assessment. In their approach, the embryo dispensation, 
compound delivery, incubation, imaging and analysis were fully automated. However, neither 
the positioning of the embryos nor the suppression of embryo movement was described. And 
for a more detailed effect analysis they had to use a manual assessment as well (Letamendia et 
al., 2012). They could show that automated computer-based phenotypic analysis of zebrafish 
embryos is feasible and beneficial, but currently, there are still bottlenecks. Nevertheless, the 
application of an automated assessment method for the here defined fluorescence endpoints, 
opens up new possibilities for the application of the zFET also for HTS chemical or drug 
screens. 
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To get an idea about the personnel requirements and costs and an insight into optimization 
strategies of the zFET, a cost benefit analysis of the different toxicity assessment methods 
was performed. Exemplary costs of a fish embryo toxicity test comprising of ten dilution 
series of one sample from the environment (e.g., effluent from sewage) or of one unknown 
chemical, respectively, were listed to compare the different assessment methods: the standard 
zFET according to OECD 236 (test method I), fluorescence assessment using transgenic 
zebrafish embryos (test method II) or whole mount antibody staining (test method III) or vital 
staining with acridine orange (AO) (test method IV). The price of a fish embryo test 
according to the Fraunhofer IME price list (2012) was used as basis for the calculations. The 
principle test design was assumed to be identical for all methods. Thus, the amount of the 
consumables (basic material, like multi well plates, pipettes, etc.) as well as of the fixed 
overheads (e.g., energy costs: water, light; etc.) was the same for all calculations. 
Additionally, the cost calculation was performed for a manually performed method (A) and a 
computer/robotic automated method (B).  
The manual standard test strategy according to the OECD 236, as considered for calculation 
A, was with 3750 € the most cost-efficient method compared to the fluorescence methods 
(3810 – 3950 €). For the manual fluorescence methods, the costs increased by ~ 1.6% 
performing vital staining with AO, by ~ 2% using transgenic zebrafish embryos and by ~ 5% 
performing whole mount antibody staining. When comparing the costs of each method with 
the manually (A) respectively automated (B) performance, the costs of the standard zFET 
method could only be reduced by 2%. The other methods would achieve a cost reduction of 4 
– 6% by automating the steps of handling and assessment. Additional costs of the required 
tools (e.g., software for the automation) were not included in the calculation since they were 
difficult to estimate. However, due to the automation of the steps in the fluorescence 
assessment, the test method II and IV could become more cost-efficient as the conventional 
zFET. 
To conclude, on the basis of this cost calculation, the fluorescence assessments within the 
zFET become only attractive with computer-based automation. Consequently, manually 
performed assessment of the fluorescence methods is unprofitable for regular use. The 
implementation of the fluorescence endpoints alone would not lead to any reduction in the 
cost of the zFET. However, if these endpoints were included in an automated screening 
approach, it would be a different matter, which suggested a significant reduction in costs. 
Thus, an automated image analysis would significantly improve the applicability of the zFET 
in screening assays.  
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This project developed robust fluorescence endpoints, which can be used as basis to fullfill 
the requirements of automation and enhancement of the microscopic assessment of the zFET. 
And progressing the zFET towards higher-throughput and higher tier content screening is of 
interest for both, regulatory agencies and industry. 
 
Table 1: Costs of consumables, personnel and material for toxicity testing with zebrafish embryos 
according to the FET (DIN 15088-T6). 
Costs of the FET according to DIN 15088-T6 (test method I) were calculated on the assumption of a simplified 
test strategy: one sample with ten dilution series, 10 eggs per concentration and two controls (positive and 
negative). The cost calculation was done for a manually (A) and for a computer automated (B) performed 
assessment method. BF: Bright field, n.a.: not available. 
 
Required units per 
test Test 
method I Resource Specification Manual Auto-mated 
Unit 
cost 
[€] 
A) Cost per 
test [€] 
(manual) 
B) Cost per test 
[€] (auto-
mated) 
Fish 
husbandry Eggs (piece) 120 120 1.58 190 190 
FET (DIN 
38415-T5) 
 (BF) 
Personnel Handling (sorting 
etc.) (h) 3 0,5 30 90 15 
   Assessment (h) 4 n.p. 30 120 120 
  Material Basics (amount) n.a. n.a. n.a. 1400 1400 
Benefit HTS-possible No       
  Info Mortality     
    Fixed overheads (€) 1950 1950 
      Overall cost (€) 3750 3675 
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Table 2: Costs of consumables, personnel and material for a toxicity testing with transgenic zebrafish 
embryos. 
Costs of using transgenic zebrafish (test method II) were calculated on the assumption of a simplified test 
strategy: one sample with ten dilution series, 10 eggs per concentration and two controls (positive and negative). 
The cost calculation was done for a manually (A) and for a computer automated (B) performed assessment 
method. FL: Fluorescence, n.a.: not available. 
 
Required units per 
test Test 
method II Resource Specification 
Manual Auto-mated 
Unit 
cost 
[€] 
A) Cost per 
test [€] 
(manual) 
B) Cost per test 
[€] (auto-
mated) 
Fish 
husbandry Eggs (piece) 120 120 1.58 190 190 
Transgenic 
fish line 
 (FL) Personnel Handling (sorting, 
dechorionation, 
mounting etc.) (h) 
4 1,5 30 120 45 
    Assessment (h) 6 1,5 30 120 45 
  Material Basics (amount) n.a. n.a. n.a. 1400 1400 
Benefit HTS-possible Yes       
  Info Target toxicity (Vaso-/ neurotoxic potential)   
    Fixed overheads (€) 1950 1950 
       Overall cost (€) 3839 3629 
 
Table 3: Costs of consumables, personnel and material for a toxicity testing with immunostained zebrafish 
embryos. 
Costs of using whole mount antibody staining (method III) were calculated on the assumption of a simplified test 
strategy: one sample with ten dilution series, 10 eggs per concentration and two controls (positive and negative). 
The cost calculation was done for a manually (A) and for a computer automated (B) performed assessment 
method. FL: Fluorescence, n.a.: not available. 
 
Required units per 
test Test 
method III Resource Specification Manual Auto-mated 
Unit 
cost 
[€] 
A) Cost per 
test [€] 
(manual) 
B) Cost per test 
[€] (auto-
mated) 
Fish 
husbandry Eggs (piece) 120 120 1.58 190 190 
Whole-
mount 
immuno-
staining 
 (FL) 
Personnel Handling (sorting, 
dechorionation, 
staining, 
mounting, etc.) (h) 
6 1.5 30 240 45 
   Assessment (h) 6 1.5 30 180 45 
  
Material Basics (amount) n.a. n.a. n.a. 1400 1400 
  Staining material 16 16 0.01 0.16 0.16 
   
Antibody 
(primary) 1.92 1.92 26.04 50 50 
  
 Antibody 
(secondary) 0.19 0.19 7.89 1.5 1.5 
Benefit HTS-possible No       
  Info Target toxicity (myotoxic potential)     
    Fixed overheads (€) 1950 1950 
       Overall cost (€) 3951 3681 
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Table 4: Costs of consumables, personnel and material for a toxicity testing with acridine orange stained 
zebrafish embryos. 
Costs of using vital staining with acridine orange (test method IV) were calculated on the assumption of a 
simplified test strategy: one sample with ten dilution series, 10 eggs per concentration and two controls (positive 
and negative). The cost calculation was done for a manually (A) and for a computer automated (B) performed 
assessment method. FL: Fluorescence, AO: Acridine orange, n.a.: not available. 
 
Required units per 
test Test 
method IV Resource Specification 
Manual Auto-mated 
Unit 
cost 
[€] 
A) Cost per 
test [€] 
(manual) 
B) Cost per test 
[€] (auto-
mated) 
Fish 
husbandry Eggs (piece) 120 120 1.58 190 190 
Vital 
staining 
with AO 
(FL) 
Personnel Handling (sorting, 
dechorionation, 
staining, 
mounting, etc.) (h) 
4 1.5 30 120 45 
   Assessment (h) 5 1.5 30 150 45 
  Material Basics (amount) n.a. n.a. n.a. 1400 1400 
  Staining material 16 16 0.01 0.16 0.16 
   Acridine Orange 10 10 0.1 1 1 
Benefit HTS-possible No         
  Info Target toxicity (apoptosis rate)     
   Fixed overheads (€) 1950 1950 
       Overall cost (€) 3810 3630 
 
4. 7 Conclusions and outlook 
The results of the proof-of-principle study demonstrated that the combination of different 
fluorescence endpoints enables a multi-factorial-effect analysis and contributes to a better 
understanding of the toxic mechanism of substances. The possibility of double stainings with 
fluorescent dyes of different excitation and emission wavelength would further promote the 
applications of fluorescence microscopy within the zFET. However, more chemicals with 
known and unknown toxicity mechanism have to be assessed to strengthen this hypothesis. Of 
particular interest would also be to evaluate the practicality and validity of the new endpoint 
methods for toxicity assessments of samples from the environment and also of mixtures. 
All in all, I could demonstrate that quantifiable fluorescence endpoints diminish the 
deficiencies of the traditional zFET endpoints, which are prone to low objectivity and high 
error rate and require sophisticated assessment. Additionally, a fluorescence-based analysis is 
more amenable to computer-based automation approaches, which could be far less time-
consuming and promote HTS applications.  
Long-term, it could be envisaged to apply the zFET also in screening approaches for 
environmental monitoring, pharmaceutical product validation and chemical hazard 
assessment. 
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5. Summary 
The fish embryo toxicity test (FET) is currently one of the most advocated animal alternative 
tests in ecotoxicology. To date, the application of the FET with zebrafish (zFET) has focused 
on acute toxicity assessment, where only lethal morphological effects are accounted for. An 
application of the zFET beyond acute toxicity, however, necessitates the establishment of 
more refined and quantifiable toxicological endpoints. A valuable tool in this context is the 
use of gene expression-dependent fluorescent markers and staining methods that can even be 
measured in vivo.  
In this thesis all sublethal morphological effects occurring in the embryos were determined by 
bright field microscopy, and, in parallel, fluorescent transgenic zebrafish embryos of 
Tg(fli1:EGFP)y1  were used to gain supplementary information on i) defects of blood vessel 
development, ii) Tg(gfap:GFP) embryos for detecting effects on radial glial cell development, 
iii) fluorescent staining with antibody against myosin to allow for conclusions on the 
myotoxic potential of substances and lastly, iv) an in vivo staining method in order to notice 
substance-induced changes in the apoptosis rate of the embryo. For a proof-of-concept study, 
the chemicals triclosan, genistein and cartap were selected as test compounds. On the basis of 
these quantifiable fluorescence endpoints, underlying toxicological mechanisms were 
elucidated what, in turn, proved to increase the sensitivity and specificity of the conventional 
zFET. In this study, the newly invented fluorescence endpoints showed a higher sensitivity of 
tested chemicals in accordance to their toxic potential (vaso-, neuro-, myotoxic or apoptotic 
potential), since effects were determined at lower concentrations in the test approach. The 
analysis of the ISV (intersegmental vessel)-length in Tg(fli1:EGFP)y1 enabled an in vivo 
detection of (vaso-) toxicity already in 24 hpf embryos. Moreover, two of the fluorescence 
endpoints methods (ii and iv) were able to link cellular effects of disturbed neural 
development and increased cell death to the molecular initiating events, what could contribute 
to the acceptance and application of gene expression profile data in risk assessment.  
Furthermore, the results demonstrate that quantifying fluorescence endpoints prevents 
deficiencies of the traditional zFET, which are low objectivity, high error rate and 
sophisticated assessment. Additionally, the fluorescence analysis depicted the potential for 
computer-based automated image analysis, what would significantly improve the applicability 
of the zFET in industrial used high-throughput screenings.  
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6. Zusammenfassung 
Der Fischembryotoxizitätstest (FET) wird in der Ökotoxikologie seit Jahren als 
vielversprechende Alternativmethode zum Tierversuch diskutiert. Bislang wurde der 
Einsatzschwerpunkt des FETs mit dem Zebrafisch (zFET) ausschließlich bei der Ermittlung 
akuter Toxizitätsdaten von Chemikalien angesehen, bei der nur letale morphologische Effekte 
zum Tragen kommen. Für die Anwendung des FETs bei der Bewertung toxikologischer 
Wirkungen von Chemikalien, die weit über die akute Toxizität hinausgeht, werden 
weiterreichende, spezifische und vor allem quantifizierbare toxikologische Testendpunkte 
benötigt. Genexpressionsabhängige Fluoreszenzmarker und Färbemethoden die u.a. eine in 
vivo Detektion ermöglichen, bieten solch eine Möglichkeit.  
Innerhalb dieser Arbeit wurden alle in den Embryos auftretenden morphologischen Effekte 
mittels Hellfeld-Mikroskopie bestimmt. Gleichzeitig wurden anhand von fluoreszierenden, 
transgenen Zebrafischembryos der Linie Tg(fli1:EGFP)y1 zusätzliche Informationen zu i) 
Defekten auf die Blutgefäßentwicklung, ii) Tg(gfap:GFP) Embryos für die Detektion von 
Effekten auf die Radialglialzellen-Entwicklung, iii) Fluoreszenzfärbungen mittels spezifischer 
Antikörper gegen Myosin um Rückschlüsse auf das myotoxische Potential von Substanzen zu 
ermöglichen und zu letzt, iv) eine in vivo Färbemethode um Substanzinduzierte 
Veränderungen innerhalb der Apoptoserate der Embryos festzustellen, eingesetzt.  
Für eine Proof-of-concept-Analyse wurden anschließend Triclosan, Genistein und Cartap als 
Modellsubstanzen gewählt. Anhand der Fluoreszenzendpunkte konnten zugrundeliegende 
toxikologische Wirkmechanismen aufgezeigt werden, was zu einer Steigerung der Sensitivität 
und Spezifität des konventionellen zFETs führte. Es konnten Effekte bereits in geringeren 
Konzentrationen festgestellt werden, was eine erhöhte Sensitivität gegenüber den getesteten 
Substanzen in Anbetracht ihres primär toxischen Potentials (vaso-, neuro-, myotoxisch oder 
apoptotisch) unter Beweis stellte. Anhand der ISV-Längenmessung der Tg(fli1:EGFP)y1 Linie 
konnte sogar eine in vivo Identifizierung von (Vaso-) Toxizität bereits in 24 hpf Embryos 
erfolgen. Ferner konnte mittels zweier Fluoreszenzendpunkt-Methoden (ii und iv) eine 
Verknüpfung von Effekten auf der zellulärer Ebene, wie die gestörte Neuronalentwicklung 
und der gesteigerte Zelltod, mit den dazugehörigen, sogenannten initiierenden Ereignissen auf 
der molekularen Ebene, aufgezeigt werden. Dies untermauert die Anwendbarkeit von 
Genexpressionsprofilen in der Umweltrisikoanalyse.  
Zudem zeigen die Ergebnisse, dass die Defizite des klassischen zFETs, wie die geringe 
Objektivität, die hohe Fehlerrate sowie die aufwändige Auswertung, durch die 
Quantifizierung der Fluoreszenzendpunkte vermindert werden können. Auch wird die 
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Möglichkeit für eine Computergestützte, automatisierte Bildanalyse aufgezeigt, was die 
Anwendbarkeit des zFET für industriell einsetzbare Hochdurchsatz-Screenings signifikant 
steigern würde.  
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8. Appendix 
8. 1 Listing of all morphological effects recorded in the zFET 
Table 5: Mean percentage of morphological effects detected in the bright field assessment of the zFET 
according to the background paper of Braunbeck and Lammert (2006) for the treatment with ethanol 
[%].  
Ethanol [%] 0.00 0.50 0.71 1.00 1.41 2.00 
Normally developed eggs 0,0% 33,3% 30,6% 33,3% 19,4% 16,7% 
Eggs with any observed Effect 0,0% 0,0% 2,8% 0,0% 13,9% 16,7% 
Mortality* 0,0% 0,0% 0,0% 0,0% 2,8% 2,8% 
*Coagulated 0,0% 0,0% 0,0% 0,0% 2,8% 0,0% 
*No detachment of tail 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Somites 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*No differentiation 0,0% 0,0% 0,0% 0,0% 0,0% 2,8% 
*Exitus 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Altered formation of Somites 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
No formation of Eyes 0,0% 0,0% 0,0% 0,0% 2,8% 5,6% 
No spont. movement 0,0% 0,0% 0,0% 0,0% 0,0% 2,8% 
Odema 0,0% 0,0% 2,8% 0,0% 8,3% 8,3% 
Malformation of Head 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Malform. of sacculi/otoliths 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Malformation of tail 0,0% 0,0% 0,0% 0,0% 0,0% 2,8% 
Malformation of heart 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Modified chorda structure 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Yolk deformation 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
General growth retardation 0,0% 0,0% 0,0% 0,0% 0,0% 2,8% 
Other Effect 1: () 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
24
 h
pf
 
Other Effect 2: () 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Normally developed eggs [%] 62,5% 91,8% 90,3% 70,8% 22,2% 16,7% 
Eggs with any observed Effect [%] 4,2% 8,2% 9,7% 29,2% 77,8% 83,3% 
Mortality* 2,8% 4,1% 2,8% 0,0% 9,7% 18,1% 
*Coagulated 2,8% 4,1% 2,8% 0,0% 8,3% 1,4% 
*No detachment of tail 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Somites 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Heartbeat 0,0% 0,0% 0,0% 0,0% 1,4% 11,1% 
*No differentiation 0,0% 0,0% 0,0% 0,0% 0,0% 5,6% 
*Exitus 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Altered formation of Somites 1,4% 0,0% 0,0% 0,0% 0,0% 0,0% 
No formation of Eyes 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
No spont. movement 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Odema 0,0% 2,8% 2,8% 20,8% 47,2% 59,7% 
Reduced Heart-beat/Blood circ. 0,0% 2,8% 2,8% 19,4% 61,1% 51,4% 
Pigmentation 0,0% 1,3% 0,0% 0,0% 0,0% 0,0% 
Malformation of Head 1,4% 0,0% 0,0% 0,0% 6,9% 13,9% 
Malform. of sacculi/otoliths 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Malformation of tail 1,4% 0,0% 0,0% 1,4% 4,2% 13,9% 
Malformation of heart 0,0% 0,0% 1,4% 5,6% 27,8% 44,4% 
Modified chorda structure 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Yolk deformation 0,0% 0,0% 0,0% 0,0% 2,8% 1,4% 
General growth retardation 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Other Effect 1: () 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
48
 h
pf
 
Other Effect 2: () 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
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Table 6: Mean percentage of morphological effects detected in the bright field assessment of the zFET 
according to the background paper of Braunbeck and Lammert (2006) for the treatment with SU4312 
[µM].   
 
SU4312 [µM] 0.00 0.38 0.61 0.91 1.44 2.23 3.48 
Normally developed eggs 96,1% 96,6% 86,4% 88,0% 70,3% 58,6% 48,6% 
Eggs with any observed Effect 3,9% 3,4% 13,6% 12,0% 29,7% 41,4% 51,4% 
Mortality* 3,0% 2,5% 5,6% 9,2% 18,9% 27,1% 37,3% 
*Coagulated 3,0% 2,5% 5,6% 9,2% 18,0% 25,0% 36,6% 
*No detachment of tail 0,0% 0,0% 0,0% 0,0% 0,0% 1,4% 0,7% 
*No Somites 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*No differentiation 0,0% 0,0% 0,7% 0,0% 0,9% 0,7% 0,0% 
*Exitus 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Altered formation of Somites 0,0% 0,0% 0,7% 0,0% 0,9% 0,0% 0,0% 
No formation of Eyes 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,7% 
No spont. movement 0,0% 0,0% 3,0% 0,0% 2,3% 1,9% 0,0% 
Odema 1,9% 0,9% 5,2% 0,9% 5,3% 8,5% 9,8% 
Malformation of Head 0,0% 0,0% 0,0% 0,0% 0,9% 0,9% 0,0% 
Malform. of sacculi/otoliths 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Malformation of tail 0,0% 0,0% 0,0% 0,0% 0,9% 0,0% 0,0% 
Malformation of heart 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Modified chorda structure 0,0% 0,0% 0,0% 0,0% 0,9% 1,9% 0,0% 
Yolk deformation 0,0% 0,0% 0,0% 0,0% 0,9% 0,7% 0,0% 
General growth retardation 0,0% 0,0% 0,0% 0,0% 0,0% 3,9% 0,0% 
Other Effect 1: () 0,0% 0,0% 0,7% 0,0% 1,3% 0,0% 2,4% 
24
 h
pf
 
Other Effect 2: () 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Normally developed eggs [%] 94,4% 94,2% 90,2% 87,6% 72,3% 47,8% 36,4% 
Eggs with any observed Effect [%] 5,6% 5,8% 9,8% 12,4% 27,7% 52,2% 63,6% 
Mortality* 3,0% 2,5% 6,3% 8,3% 16,8% 26,6% 33,9% 
*Coagulated 3,0% 2,5% 6,3% 8,3% 16,8% 25,9% 33,9% 
*No detachment of tail 0,0% 0,0% 0,0% 0,0% 0,0% 0,7% 0,0% 
*No Somites 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Heartbeat 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*No differentiation 0,0% 0,0% 0,7% 0,0% 0,0% 0,0% 0,0% 
*Exitus 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Altered formation of Somites 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
No formation of Eyes 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
No spont. movement 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Odema 0,0% 1,9% 1,4% 3,5% 4,9% 17,8% 17,8% 
Reduced Heart-beat/Blood circ. 1,7% 1,6% 0,7% 0,9% 0,7% 13,2% 10,9% 
Pigmentation 0,0% 0,0% 0,7% 0,0% 0,0% 8,1% 10,3% 
Malformation of Head 0,8% 0,0% 0,7% 2,8% 2,8% 0,0% 1,0% 
Malform. of sacculi/otoliths 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Malformation of tail 0,0% 0,0% 0,0% 0,0% 0,0% 0,9% 1,0% 
Malformation of heart 0,0% 0,7% 1,4% 1,6% 2,1% 13,8% 6,3% 
Modified chorda structure 0,0% 0,0% 0,7% 0,9% 0,0% 0,9% 1,0% 
Yolk deformation 0,0% 0,0% 0,7% 0,9% 1,6% 8,3% 6,5% 
General growth retardation 0,0% 0,0% 0,0% 0,0% 0,0% 0,7% 0,0% 
Other Effect 1: () 0,0% 0,0% 0,0% 0,9% 2,9% 0,0% 1,6% 
48
 h
pf
 
Other Effect 2: () 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
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Table 7: Mean percentage of morphological effects detected in the bright field assessment of the zFET 
according to the background paper of Braunbeck and Lammert (2006) for the treatment with 
pentoxifylline [µM].  
 
Pentoxifylline [µM] 0.00 179.66 303.83 593.22 1019.44 
Normally developed eggs 98,6% 97,4% 89,2% 86,8% 88,9% 
Eggs with any observed Effect 1,4% 2,6% 10,8% 13,2% 11,1% 
Mortality* 1,4% 2,6% 5,2% 9,7% 2,1% 
*Coagulated 1,4% 2,6% 5,2% 9,7% 2,1% 
*No detachment of tail 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Somites 0,0% 0,0% 0,0% 0,0% 0,0% 
*No differentiation 0,0% 0,0% 0,0% 0,0% 0,0% 
*Exitus 0,0% 0,0% 0,0% 0,0% 0,0% 
Altered formation of Somites 0,0% 0,0% 0,0% 0,0% 1,4% 
No formation of Eyes 0,0% 0,0% 0,0% 0,0% 0,0% 
No spont. movement 0,0% 0,0% 8,3% 0,0% 4,2% 
Odema 0,0% 0,0% 5,6% 0,0% 0,0% 
Malformation of Head 0,0% 0,0% 0,0% 0,0% 0,0% 
Malform. of sacculi/otoliths 0,0% 0,0% 2,8% 0,0% 0,0% 
Malformation of tail 0,0% 0,0% 2,8% 0,7% 3,5% 
Malformation of heart 0,0% 0,0% 0,0% 0,0% 0,0% 
Modified chorda structure 0,0% 0,0% 0,0% 0,0% 0,0% 
Yolk deformation 0,0% 0,0% 0,0% 0,0% 0,0% 
General growth retardation 0,0% 0,0% 0,0% 0,0% 0,0% 
Other Effect 1: () 0,0% 0,0% 0,0% 0,0% 0,0% 
24
 h
pf
 
Other Effect 2: () 0,0% 0,0% 0,0% 0,0% 0,0% 
Normally developed eggs [%] 95,9% 94,7% 80,1% 47,9% 16,7% 
Eggs with any observed Effect [%] 4,1% 5,3% 19,9% 52,1% 83,3% 
Mortality* 1,4% 2,6% 5,2% 11,1% 3,5% 
*Coagulated 1,4% 2,6% 5,2% 9,7% 2,1% 
*No detachment of tail 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Somites 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Heartbeat 0,0% 0,0% 0,0% 1,4% 1,4% 
*No differentiation 0,0% 0,0% 0,0% 0,0% 0,0% 
*Exitus 0,0% 0,0% 0,0% 0,0% 0,0% 
Altered formation of Somites 0,0% 0,0% 0,0% 0,0% 0,0% 
No formation of Eyes 0,0% 0,0% 0,0% 0,0% 0,0% 
No spont. movement 0,0% 0,0% 0,6% 0,0% 0,0% 
Odema 0,0% 0,0% 1,3% 12,5% 45,8% 
Reduced Heart-beat/Blood circ. 2,8% 2,8% 6,9% 19,4% 68,8% 
Pigmentation 0,0% 1,3% 5,8% 8,3% 2,1% 
Malformation of Head 0,0% 0,0% 1,3% 0,0% 0,7% 
Malform. of sacculi/otoliths 0,0% 0,0% 0,0% 0,0% 0,0% 
Malformation of tail 0,0% 0,0% 0,0% 4,2% 9,0% 
Malformation of heart 2,8% 2,8% 5,6% 6,9% 26,4% 
Modified chorda structure 0,0% 0,0% 1,3% 17,4% 44,4% 
Yolk deformation 0,0% 0,0% 0,0% 0,0% 0,0% 
General growth retardation 0,0% 0,0% 0,0% 0,0% 0,0% 
Other Effect 1: () 0,0% 0,0% 0,0% 0,0% 0,0% 
48
 h
pf
 
Other Effect 2: () 0,0% 0,0% 0,0% 0,0% 0,0% 
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Table 8: Mean percentage of morphological effects detected in the bright field assessment of the zFET 
according to the background paper of Braunbeck and Lammert (2006) for the treatment with triclosan 
[µM].  
 
Triclosan [µM] 0.00 1.73 1.93 2.18 2.45 2.76 
Normally developed eggs 97,2% 74,9% 75,0% 69,8% 59,6% 28,8% 
Eggs with any observed Effect 2,8% 25,1% 25,0% 30,2% 40,4% 62,8% 
Mortality* 1,4% 2,8% 1,4% 1,4% 1,4% 9,7% 
*Coagulated 2,8% 4,3% 2,8% 2,8% 2,8% 9,7% 
*No detachment of tail 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Somites 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*No differentiation 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*Exitus 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Altered formation of Somites 0,0% 0,0% 1,3% 1,4% 4,2% 4,2% 
No formation of Eyes 0,0% 2,8% 1,3% 1,4% 2,8% 1,3% 
No spont. movement 0,7% 5,6% 5,1% 6,8% 16,4% 31,5% 
Odema 0,0% 8,3% 5,4% 9,6% 8,4% 9,6% 
Malformation of Head 0,0% 5,6% 7,8% 6,9% 2,8% 20,4% 
Malform. of sacculi/otoliths 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Malformation of tail 0,7% 1,4% 5,4% 6,8% 4,3% 20,7% 
Malformation of heart 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Modified chorda structure 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Yolk deformation 0,7% 0,0% 0,0% 0,0% 1,5% 1,3% 
General growth retardation 0,0% 1,4% 2,6% 2,8% 2,9% 2,7% 
Other Effect 1: () 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
24
 h
pf
 
Other Effect 2: () 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Normally developed eggs [%] 95,8% 72,2% 76,3% 68,1% 42,6% 6,9% 
Eggs with any observed Effect [%] 4,2% 27,8% 23,7% 31,9% 57,4% 93,1% 
Mortality* 1,4% 5,6% 1,4% 0,0% 11,2% 35,1% 
*Coagulated 2,8% 1,4% 2,8% 0,0% 2,8% 21,8% 
*No detachment of tail 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Somites 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Heartbeat 0,0% 4,2% 0,0% 0,0% 7,1% 19,0% 
*No differentiation 0,0% 0,0% 0,0% 0,0% 2,8% 2,7% 
*Exitus 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Altered formation of Somites 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
No formation of Eyes 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
No spont. movement 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Odema 0,0% 6,9% 4,1% 11,1% 11,1% 19,3% 
Reduced Heart-beat/Blood circ. 1,4% 16,8% 13,0% 9,7% 25,7% 44,2% 
Pigmentation 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Malformation of Head 0,0% 6,9% 5,3% 5,6% 15,7% 12,2% 
Malform. of sacculi/otoliths 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Malformation of tail 1,4% 8,3% 5,3% 5,6% 14,2% 32,9% 
Malformation of heart 0,0% 12,5% 14,5% 23,6% 39,1% 49,7% 
Modified chorda structure 0,0% 0,0% 0,0% 0,0% 0,0% 2,6% 
Yolk deformation 1,4% 8,3% 1,3% 2,8% 2,9% 11,1% 
General growth retardation 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Other Effect 1: () 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
48
 h
pf
 
Other Effect 2: () 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
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Table 9: Mean percentage of morphological effects detected in the bright field assessment of the zFET 
according to the background paper of Braunbeck and Lammert (2006) for the treatment with genistein 
[µM].  
 
Genistein [µM] 0.00 7.40 8.81 10.47 12.43 14.80 
Normally developed eggs 97,1% 95,8% 83,3% 79,8% 70,8% 12,5% 
Eggs with any observed Effect 2,9% 4,2% 16,7% 20,2% 29,2% 87,5% 
Mortality* 2,9% 0,0% 8,3% 1,9% 0,0% 2,1% 
*Coagulated 2,9% 0,0% 8,3% 1,9% 0,0% 2,1% 
*No detachment of tail 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Somites 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*No differentiation 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*Exitus 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Altered formation of Somites 0,0% 0,0% 0,0% 2,1% 0,0% 8,3% 
No formation of Eyes 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
No spont. movement 1,5% 2,1% 0,0% 0,0% 0,0% 10,4% 
Odema 0,0% 2,1% 6,3% 2,1% 14,6% 43,8% 
Malformation of Head 0,0% 2,1% 2,1% 18,3% 12,5% 64,6% 
Malform. of sacculi/otoliths 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Malformation of tail 0,0% 0,0% 0,0% 2,1% 0,0% 20,8% 
Malformation of heart 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Modified chorda structure 0,0% 0,0% 0,0% 4,2% 8,3% 31,3% 
Yolk deformation 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
General growth retardation 0,0% 0,0% 0,0% 0,0% 0,0% 2,1% 
Other Effect 1: () 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
24
 h
pf
 
Other Effect 2: () 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Normally developed eggs [%] 91,1% 91,7% 53,0% 12,4% 5,6% 1,4% 
Eggs with any observed Effect [%] 8,9% 8,3% 47,0% 87,6% 94,4% 98,6% 
Mortality* 6,1% 2,8% 8,5% 5,4% 1,4% 27,8% 
*Coagulated 4,7% 2,8% 8,5% 5,4% 1,4% 8,3% 
*No detachment of tail 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Somites 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Heartbeat 0,0% 0,0% 0,0% 0,0% 0,0% 18,1% 
*No differentiation 0,0% 0,0% 0,0% 0,0% 0,0% 1,4% 
*Exitus 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Altered formation of Somites 0,0% 0,0% 5,8% 13,9% 22,2% 48,6% 
No formation of Eyes 0,0% 0,0% 0,0% 19,4% 25,0% 33,3% 
No spont. movement 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Odema 1,4% 0,0% 2,8% 17,9% 38,9% 72,2% 
Reduced Heart-beat/Blood circ. 1,4% 4,2% 15,3% 27,1% 33,3% 68,1% 
Pigmentation 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Malformation of Head 1,4% 1,4% 22,2% 67,2% 86,1% 88,9% 
Malform. of sacculi/otoliths 0,0% 2,8% 0,0% 5,6% 4,2% 1,4% 
Malformation of tail 2,8% 1,4% 15,3% 41,6% 55,6% 87,5% 
Malformation of heart 0,0% 1,4% 5,6% 41,1% 56,9% 88,9% 
Modified chorda structure 0,0% 0,0% 0,0% 12,1% 25,0% 26,4% 
Yolk deformation 2,8% 0,0% 0,0% 2,8% 1,4% 1,4% 
General growth retardation 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
Other Effect 1: () 1,4% 0,0% 0,0% 0,0% 0,0% 0,0% 
48
 h
pf
 
Other Effect 2: () 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 
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Table 10: Mean percentage of morphological effects detected in the bright field assessment of the zFET 
according to the background paper of Braunbeck and Lammert (2006) for the treatment with cartap 
[µM].  
 
Cartap [µM] 0.00 0.42 0.55 0.67 0.84 
Normally developed eggs 94,2% 94,5% 65,2% 35,1% 5,6% 
Eggs with any observed Effect 5,8% 5,5% 34,8% 64,9% 94,4% 
Mortality* 4,7% 4,6% 8,5% 3,7% 7,4% 
*Coagulated 3,2% 4,6% 8,5% 3,7% 4,6% 
*No detachment of tail 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Somites 0,0% 0,0% 0,0% 0,0% 0,0% 
*No differentiation 0,5% 0,0% 0,0% 0,0% 0,0% 
*Exitus 0,0% 0,0% 0,0% 0,0% 0,0% 
Altered formation of Somites 0,0% 0,0% 0,0% 0,0% 0,0% 
No formation of Eyes 0,0% 0,0% 1,0% 0,0% 0,0% 
No spont. movement 0,0% 0,0% 0,0% 0,0% 0,9% 
Odema 0,0% 0,0% 2,9% 0,0% 1,9% 
Malformation of Head 0,0% 0,0% 8,9% 18,8% 13,9% 
Malform. of sacculi/otoliths 0,0% 0,0% 0,0% 0,0% 0,0% 
Malformation of tail 0,0% 0,0% 2,9% 0,9% 1,9% 
Malformation of heart 0,0% 0,0% 0,0% 5,6% 11,1% 
Modified chorda structure 0,0% 0,9% 19,2% 48,3% 73,6% 
Yolk deformation 0,0% 0,0% 1,0% 0,0% 0,0% 
General growth retardation 0,0% 0,0% 0,0% 0,0% 0,0% 
Other Effect 1: () 0,0% 0,0% 0,0% 0,0% 0,0% 
24
 h
pf
 
Other Effect 2: () 0,0% 0,0% 0,0% 0,0% 0,0% 
Normally developed eggs [%] 93,5% 94,4% 79,6% 37,8% 5,1% 
Eggs with any observed Effect [%] 6,5% 5,6% 20,4% 62,2% 94,9% 
Mortality* 5,1% 4,6% 8,3% 5,1% 6,0% 
*Coagulated 3,2% 2,8% 8,3% 3,7% 5,1% 
*No detachment of tail 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Somites 0,0% 0,0% 0,0% 0,0% 0,0% 
*No Heartbeat 0,0% 0,0% 0,0% 1,4% 0,0% 
*No differentiation 0,5% 0,0% 0,0% 0,0% 0,0% 
*Exitus 0,0% 0,0% 0,0% 0,0% 0,0% 
Altered formation of Somites 0,0% 0,0% 0,0% 2,8% 15,3% 
No formation of Eyes 0,0% 0,0% 0,0% 0,0% 0,0% 
No spont. movement 0,0% 0,0% 0,0% 0,0% 0,0% 
Odema 0,0% 0,0% 0,0% 1,4% 1,4% 
Reduced Heart-beat/Blood circ. 0,0% 0,0% 0,0% 2,3% 0,0% 
Pigmentation 0,0% 0,0% 1,0% 52,0% 87,5% 
Malformation of Head 0,0% 0,0% 0,9% 0,9% 4,2% 
Malform. of sacculi/otoliths 0,0% 0,0% 0,0% 0,0% 0,0% 
Malformation of tail 0,9% 0,0% 2,3% 1,4% 1,4% 
Malformation of heart 0,0% 0,9% 2,3% 4,2% 2,8% 
Modified chorda structure 0,0% 0,0% 7,4% 53,5% 87,5% 
Yolk deformation 0,0% 0,0% 1,9% 0,9% 0,0% 
General growth retardation 0,0% 0,0% 0,0% 0,0% 0,0% 
Other Effect 1: () 0,0% 0,0% 0,0% 0,0% 0,0% 
48
 h
pf
 
Other Effect 2: () 0,0% 0,0% 0,0% 0,0% 0,0% 
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